| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | NEFM NEFH POTEE DES KRT71 PLEC VIM KRT9 POTEF LMNB2 INA LMNA LMNB1 POTEI | 4.47e-11 | 130 | 198 | 14 | GO:0005200 |
| GeneOntologyMolecularFunction | acetylcholine receptor regulator activity | 6.36e-09 | 27 | 198 | 7 | GO:0030548 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor regulator activity | 8.41e-09 | 28 | 198 | 7 | GO:0099602 | |
| GeneOntologyMolecularFunction | structural molecule activity | KRT72 EPPK1 KRT74 RPS6 KRT80 NEFM NEFH POTEE DES KRT71 PLEC VIM KRT9 POTEF NUP98 LMNB2 KRT23 INA LMNA LMNB1 MACF1 CTNNA1 POTEI PRPH | 8.81e-06 | 891 | 198 | 24 | GO:0005198 |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.48e-05 | 32 | 198 | 5 | GO:0099186 | |
| GeneOntologyMolecularFunction | keratin filament binding | 1.88e-05 | 6 | 198 | 3 | GO:1990254 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.34e-05 | 118 | 198 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH10 MYO1A NEFM NEFH DES SYNE2 SCN5A KCNMA1 KIF28P PLEC FLNB FLNC BIN1 CLIP2 KIF26B SYNE1 IFT81 DYRK1A GRIA2 FSD1 BLOC1S2 MICAL2 MACF1 CTNNA1 FHDC1 MYO15A | 3.46e-05 | 1099 | 198 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX47 MYH10 MYO1A CCT3 MCM5 CHD2 KIF28P DNAH5 DNAH3 LONP2 KIF26B UBA2 DNAH1 MACF1 MYO15A TOP2B CDK7 HELLS | 4.25e-05 | 614 | 198 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 5.75e-05 | 42 | 198 | 5 | GO:0098918 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 7.72e-05 | 9 | 198 | 3 | GO:0070016 | |
| GeneOntologyMolecularFunction | actin binding | MYH10 MYO1A SYNE2 KCNMA1 PLEC FLNB FLNC BIN1 SYNE1 DYRK1A MICAL2 MACF1 CTNNA1 FHDC1 MYO15A | 9.13e-05 | 479 | 198 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | actin filament binding | 9.32e-05 | 227 | 198 | 10 | GO:0051015 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear lamina | 9.78e-05 | 2 | 198 | 2 | GO:0160123 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 1.49e-04 | 11 | 198 | 3 | GO:0098973 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.62e-04 | 52 | 198 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | protein kinase binding | RPS6 NEFH POTEE NELL1 SCN5A SPDYE21 SPDYE5 SPDYE2B SPDYE4 SPDYE1 VIM POTEF GRIA2 SPDYE18 LMNB1 MICAL2 SPDYE2 POTEI MAP2K3 SPDYE6 SPDYE16 | 1.65e-04 | 873 | 198 | 21 | GO:0019901 |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 1.98e-04 | 12 | 198 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | kinase binding | RPS6 NEFH POTEE NELL1 SCN5A SPDYE21 SPDYE5 PLG SPDYE2B SPDYE4 SPDYE1 VIM POTEF GRIA2 SPDYE18 LMNB1 MICAL2 SPDYE2 POTEI MAP2K3 SPDYE6 SPDYE16 | 2.58e-04 | 969 | 198 | 22 | GO:0019900 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic intermediate filament cytoskeleton | 2.92e-04 | 3 | 198 | 2 | GO:0099184 | |
| GeneOntologyMolecularFunction | intermediate filament binding | 4.00e-04 | 15 | 198 | 3 | GO:0019215 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 6.54e-04 | 70 | 198 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 7.02e-04 | 18 | 198 | 3 | GO:0015280 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 7.02e-04 | 18 | 198 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.02e-04 | 18 | 198 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 7.82e-04 | 42 | 198 | 4 | GO:0051721 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 8.55e-04 | 43 | 198 | 4 | GO:0030280 | |
| GeneOntologyMolecularFunction | osmolarity-sensing monoatomic cation channel activity | 9.59e-04 | 5 | 198 | 2 | GO:1990760 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 9.59e-04 | 5 | 198 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 1.43e-03 | 6 | 198 | 2 | GO:0015277 | |
| GeneOntologyMolecularFunction | osmosensor activity | 1.43e-03 | 6 | 198 | 2 | GO:0005034 | |
| GeneOntologyMolecularFunction | ankyrin binding | 1.47e-03 | 23 | 198 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.67e-03 | 24 | 198 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.11e-03 | 26 | 198 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.62e-03 | 28 | 198 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 2.63e-03 | 8 | 198 | 2 | GO:0003916 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.76e-03 | 140 | 198 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.52e-03 | 31 | 198 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | tubulin binding | NEFM NEFH KIF28P CLIP2 KIF26B IFT81 DYRK1A FSD1 BLOC1S2 MACF1 FHDC1 | 3.74e-03 | 428 | 198 | 11 | GO:0015631 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | KRT72 EPPK1 KRT74 KRT80 NEFM NEFH DES KRT71 PLEC VIM KRT9 KRT23 INA MACF1 PRPH | 3.37e-14 | 99 | 198 | 15 | GO:0045104 |
| GeneOntologyBiologicalProcess | intermediate filament-based process | KRT72 EPPK1 KRT74 KRT80 NEFM NEFH DES KRT71 PLEC VIM KRT9 KRT23 INA MACF1 PRPH | 3.93e-14 | 100 | 198 | 15 | GO:0045103 |
| GeneOntologyBiologicalProcess | intermediate filament organization | KRT72 EPPK1 KRT74 KRT80 NEFM NEFH DES KRT71 PLEC VIM KRT9 KRT23 INA | 2.97e-13 | 75 | 198 | 13 | GO:0045109 |
| GeneOntologyBiologicalProcess | nucleus localization | 3.06e-10 | 44 | 198 | 9 | GO:0051647 | |
| GeneOntologyBiologicalProcess | nuclear migration | 9.18e-10 | 34 | 198 | 8 | GO:0007097 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 2.80e-09 | 25 | 198 | 7 | GO:0045737 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein kinase activity | 6.74e-09 | 28 | 198 | 7 | GO:1904031 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT72 MYH10 EPPK1 MYO1A KRT74 MEF2C KRT80 NEFM NEFH DES KRT71 PLEC VIM FLNC KRT9 BIN1 MIA3 CLIP2 DYRK1A ARHGEF18 FSD1 S1PR1 KRT23 INA MICAL2 FHDC1 MYO15A PCM1 | 1.47e-07 | 957 | 198 | 28 | GO:0097435 |
| GeneOntologyBiologicalProcess | microtubule-based transport | NEFM NEFH CFAP54 SYNE2 KIF28P DNAH5 IFT22 IFT20 IFT81 BLOC1S2 CCDC39 MADD DNAH1 PCM1 | 1.68e-07 | 253 | 198 | 14 | GO:0099111 |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 9.34e-07 | 35 | 198 | 6 | GO:0099188 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | NEFM NEFH CFAP54 SYNE2 VPS13A KIF28P DNAH5 DNAH3 IFT22 KIF26B IFT20 IFT81 APOB BLOC1S2 CCDC39 MADD DNAH1 PCM1 | 1.39e-06 | 493 | 198 | 18 | GO:0007018 |
| GeneOntologyBiologicalProcess | nuclear pore localization | 8.59e-06 | 5 | 198 | 3 | GO:0051664 | |
| GeneOntologyBiologicalProcess | transport along microtubule | 2.15e-05 | 197 | 198 | 10 | GO:0010970 | |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein serine/threonine kinase activity | 3.91e-05 | 96 | 198 | 7 | GO:0000079 | |
| GeneOntologyBiologicalProcess | intermediate filament bundle assembly | 4.71e-05 | 8 | 198 | 3 | GO:0045110 | |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein kinase activity | 5.09e-05 | 100 | 198 | 7 | GO:1904029 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | 6.65e-05 | 225 | 198 | 10 | GO:0030705 | |
| GeneOntologyBiologicalProcess | microtubule-based process | NEFM NEFH CFAP54 SYNE2 VPS13A KIF28P TACC1 DNAH5 DNAH3 IFT22 CLIP2 KIF26B IFT20 IFT81 DYRK1A APOB FSD1 BLOC1S2 CCDC39 MADD DNAH1 LMNA MACF1 PCM1 | 8.26e-05 | 1058 | 198 | 24 | GO:0007017 |
| GeneOntologyBiologicalProcess | neurofilament cytoskeleton organization | 1.36e-04 | 11 | 198 | 3 | GO:0060052 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 2.12e-04 | 31 | 198 | 4 | GO:0098974 | |
| GeneOntologyBiologicalProcess | nucleus organization | 2.43e-04 | 170 | 198 | 8 | GO:0006997 | |
| GeneOntologyBiologicalProcess | protein-lipid complex assembly | 2.71e-04 | 33 | 198 | 4 | GO:0065005 | |
| GeneOntologyBiologicalProcess | postsynaptic intermediate filament cytoskeleton organization | 2.73e-04 | 3 | 198 | 2 | GO:0099185 | |
| GeneOntologyBiologicalProcess | neurofilament bundle assembly | 2.73e-04 | 3 | 198 | 2 | GO:0033693 | |
| GeneOntologyBiologicalProcess | protein localization to nuclear envelope | 2.93e-04 | 14 | 198 | 3 | GO:0090435 | |
| GeneOntologyBiologicalProcess | very-low-density lipoprotein particle assembly | 2.93e-04 | 14 | 198 | 3 | GO:0034379 | |
| GeneOntologyBiologicalProcess | centrosome localization | 3.42e-04 | 35 | 198 | 4 | GO:0051642 | |
| GeneOntologyBiologicalProcess | cell projection assembly | MYH10 MYO1A TBC1D2B NEFH CFAP54 SYNE2 DNAH5 PLXNB3 IFT22 IFT20 SYNE1 IFT81 S1PR1 CCDC39 DNAH1 FHDC1 PCM1 | 3.43e-04 | 685 | 198 | 17 | GO:0030031 |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 3.70e-04 | 278 | 198 | 10 | GO:0031503 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 3.82e-04 | 36 | 198 | 4 | GO:0061842 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRT72 MYH10 EPPK1 MYO1A CCT3 KRT74 MEF2C KRT80 NEFM NEFH POTEE DES KRT71 SYNE2 SCN5A KIF28P PLEC DNAH5 VIM FLNB FLNC DNAH3 KRT9 BIN1 CLIP2 KIF26B POTEF SYNE1 DYRK1A FSD1 LMNB2 CFAP210 DNAH1 KRT23 INA LMNA LMNB1 MICAL2 MACF1 FHDC1 POTEI PRPH | 5.46e-14 | 1179 | 197 | 42 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT72 MYH10 EPPK1 MYO1A CCT3 KRT74 MEF2C KRT80 NEFM NEFH POTEE DES KRT71 SYNE2 SCN5A KIF28P PLEC DNAH5 VIM FLNB FLNC DNAH3 KRT9 BIN1 CLIP2 KIF26B POTEF SYNE1 DYRK1A FSD1 LMNB2 CFAP210 DNAH1 KRT23 INA LMNA LMNB1 MICAL2 MACF1 FHDC1 POTEI PRPH | 6.86e-14 | 1187 | 197 | 42 | GO:0099081 |
| GeneOntologyCellularComponent | intermediate filament | KRT72 EPPK1 KRT74 KRT80 NEFM NEFH DES KRT71 PLEC VIM KRT9 DYRK1A LMNB2 KRT23 INA LMNA LMNB1 MACF1 PRPH | 5.39e-13 | 227 | 197 | 19 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRT72 EPPK1 KRT74 KRT80 NEFM NEFH DES KRT71 SYNE2 PLEC VIM KRT9 DYRK1A LMNB2 KRT23 INA LMNA LMNB1 MACF1 PRPH | 7.73e-13 | 263 | 197 | 20 | GO:0045111 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT72 EPPK1 MYO1A CCT3 KRT74 KRT80 NEFM NEFH POTEE DES KRT71 KIF28P PLEC DNAH5 VIM DNAH3 KRT9 CLIP2 KIF26B POTEF DYRK1A FSD1 LMNB2 CFAP210 DNAH1 KRT23 INA LMNA LMNB1 MICAL2 MACF1 FHDC1 POTEI PRPH | 3.93e-12 | 899 | 197 | 34 | GO:0099513 |
| GeneOntologyCellularComponent | neurofilament | 1.32e-07 | 14 | 197 | 5 | GO:0005883 | |
| GeneOntologyCellularComponent | postsynaptic intermediate filament cytoskeleton | 3.27e-06 | 4 | 197 | 3 | GO:0099160 | |
| GeneOntologyCellularComponent | lamin filament | 1.61e-05 | 6 | 197 | 3 | GO:0005638 | |
| GeneOntologyCellularComponent | type III intermediate filament | 1.61e-05 | 6 | 197 | 3 | GO:0045098 | |
| GeneOntologyCellularComponent | axon | MYH10 MYO1A OPN1SW NEFM NEFH POTEE SCN5A KCNMA1 PLEC VIM BIN1 TRPA1 POTEF DYRK1A GRIA2 GRIK4 BLOC1S2 ADAM22 MADD PRKCG POTEI PRPH | 3.71e-05 | 891 | 197 | 22 | GO:0030424 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 5.29e-05 | 223 | 197 | 10 | GO:0098862 | |
| GeneOntologyCellularComponent | somatodendritic compartment | BRINP3 MYH10 MYO1A RPS6 ITPR3 NEFM NEFH STRN CLCN2 VPS13A STRN4 KCNMA1 PLEC FLNB STRN3 BIN1 CLIP2 IFT20 SYNE1 DYRK1A GRIA2 APOB GRIK4 ARG1 PRKCG PRPH | 9.36e-05 | 1228 | 197 | 26 | GO:0036477 |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 9.72e-05 | 26 | 197 | 4 | GO:0099571 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.04e-04 | 114 | 197 | 7 | GO:0016528 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH10 MYO1A POTEE TAF5 FLNB FLNC BIN1 LURAP1 POTEF DYRK1A MICAL2 MACF1 CTNNA1 FHDC1 POTEI MYO15A | 1.19e-04 | 576 | 197 | 16 | GO:0015629 |
| GeneOntologyCellularComponent | cell body | BRINP3 MYH10 MYO1A CCT3 RPS6 OPN1SW ITPR3 NEFM NEFH STRN CLCN2 VPS13A KCNMA1 VIM FLNB STRN3 GRIA2 APOB GRIK4 ARG1 PRPH | 1.92e-04 | 929 | 197 | 21 | GO:0044297 |
| GeneOntologyCellularComponent | semaphorin receptor complex | 2.20e-04 | 13 | 197 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | keratin filament | 3.15e-04 | 97 | 197 | 6 | GO:0045095 | |
| GeneOntologyCellularComponent | actin filament | 4.77e-04 | 146 | 197 | 7 | GO:0005884 | |
| GeneOntologyCellularComponent | dendrite | BRINP3 MYH10 RPS6 ITPR3 NEFH STRN CLCN2 STRN4 KCNMA1 PLEC STRN3 BIN1 CLIP2 IFT20 SYNE1 DYRK1A GRIA2 GRIK4 PRKCG | 5.04e-04 | 858 | 197 | 19 | GO:0030425 |
| GeneOntologyCellularComponent | nuclear lamina | 5.08e-04 | 17 | 197 | 3 | GO:0005652 | |
| GeneOntologyCellularComponent | FAR/SIN/STRIPAK complex | 5.08e-04 | 17 | 197 | 3 | GO:0090443 | |
| GeneOntologyCellularComponent | dendritic tree | BRINP3 MYH10 RPS6 ITPR3 NEFH STRN CLCN2 STRN4 KCNMA1 PLEC STRN3 BIN1 CLIP2 IFT20 SYNE1 DYRK1A GRIA2 GRIK4 PRKCG | 5.19e-04 | 860 | 197 | 19 | GO:0097447 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | TSNAXIP1 RPS6 OPN1SW ITPR3 NELL1 SCN5A KCNMA1 PLEC VIM KRT9 SYNE1 EPG5 TG PTOV1 PIKFYVE LMNA DEF6 PRKCG CYB5R4 CDK7 | 5.47e-04 | 934 | 197 | 20 | GO:0048471 |
| GeneOntologyCellularComponent | Z disc | 5.84e-04 | 151 | 197 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | sarcomere | 6.14e-04 | 249 | 197 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | neurofibrillary tangle | 8.67e-04 | 5 | 197 | 2 | GO:0097418 | |
| GeneOntologyCellularComponent | intraciliary transport particle B | 9.67e-04 | 21 | 197 | 3 | GO:0030992 | |
| GeneOntologyCellularComponent | I band | 1.02e-03 | 166 | 197 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | myofibril | 1.18e-03 | 273 | 197 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.63e-03 | 25 | 197 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.78e-03 | 290 | 197 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | terminal bouton | 2.16e-03 | 96 | 197 | 5 | GO:0043195 | |
| GeneOntologyCellularComponent | intraciliary transport particle | 2.27e-03 | 28 | 197 | 3 | GO:0030990 | |
| GeneOntologyCellularComponent | neuronal cell body | BRINP3 MYH10 MYO1A ITPR3 NEFM NEFH STRN CLCN2 VPS13A KCNMA1 FLNB STRN3 GRIA2 APOB GRIK4 ARG1 PRPH | 2.43e-03 | 835 | 197 | 17 | GO:0043025 |
| GeneOntologyCellularComponent | sodium channel complex | 2.51e-03 | 29 | 197 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | brush border | 3.23e-03 | 152 | 197 | 6 | GO:0005903 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 3.23e-03 | 317 | 197 | 9 | GO:0032838 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 3.34e-03 | 32 | 197 | 3 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 3.34e-03 | 32 | 197 | 3 | GO:0043189 | |
| GeneOntologyCellularComponent | inner dynein arm | 3.78e-03 | 10 | 197 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | axon terminus | 3.85e-03 | 210 | 197 | 7 | GO:0043679 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 4.60e-03 | 11 | 197 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | MCM complex | 4.60e-03 | 11 | 197 | 2 | GO:0042555 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 4.60e-03 | 11 | 197 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 4.60e-03 | 11 | 197 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | hemidesmosome | 4.60e-03 | 11 | 197 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 4.60e-03 | 11 | 197 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | myelin sheath | 4.60e-03 | 217 | 197 | 7 | GO:0043209 | |
| GeneOntologyCellularComponent | microtubule | CCT3 KIF28P DNAH5 DNAH3 CLIP2 KIF26B DYRK1A FSD1 CFAP210 DNAH1 MACF1 FHDC1 | 4.80e-03 | 533 | 197 | 12 | GO:0005874 |
| GeneOntologyCellularComponent | actin-based cell projection | 4.98e-03 | 278 | 197 | 8 | GO:0098858 | |
| GeneOntologyCellularComponent | cilium | PDE6A IQCD OPN1SW CFAP54 VPS13A DNAH5 DNAH3 IFT22 IFT20 IFT81 CFAP210 CCDC39 DNAH1 FHDC1 PCM1 PMFBP1 PRPH | 5.05e-03 | 898 | 197 | 17 | GO:0005929 |
| HumanPheno | Decreased cervical spine flexion due to contractures of posterior cervical muscles | 1.47e-06 | 7 | 75 | 4 | HP:0004631 | |
| HumanPheno | Ventricular escape rhythm | 1.32e-05 | 11 | 75 | 4 | HP:0005155 | |
| HumanPheno | Third degree atrioventricular block | 1.96e-05 | 12 | 75 | 4 | HP:0001709 | |
| HumanPheno | Abnormal muscle fiber emerin | 5.94e-05 | 6 | 75 | 3 | HP:0030116 | |
| HumanPheno | Absent muscle fiber emerin | 5.94e-05 | 6 | 75 | 3 | HP:0030117 | |
| HumanPheno | Myopathy | NEFH DES CLCN1 SYNE2 SCN5A VPS13A PLEC FLNC BIN1 CLIP2 SYNE1 LMNB2 EPG5 LMNA MTTP | 1.01e-04 | 341 | 75 | 15 | HP:0003198 |
| HumanPheno | Left anterior fascicular block | 1.03e-04 | 7 | 75 | 3 | HP:0011711 | |
| MousePheno | abnormal spine curvature | KRT72 BRINP3 CHD2 NELL1 CLCN1 FLNB ANKFY1 SYNE1 EPG5 RNF14 LMNA LMNB1 TOP2B HELLS | 1.40e-05 | 318 | 157 | 14 | MP:0004174 |
| Domain | Filament | KRT72 KRT74 KRT80 NEFM NEFH DES KRT71 VIM KRT9 LMNB2 KRT23 INA LMNA LMNB1 PRPH | 4.45e-16 | 71 | 191 | 15 | SM01391 |
| Domain | IF | KRT72 KRT74 KRT80 NEFM NEFH DES KRT71 VIM KRT9 LMNB2 KRT23 INA LMNA LMNB1 PRPH | 5.57e-16 | 72 | 191 | 15 | PS00226 |
| Domain | Filament | KRT72 KRT74 KRT80 NEFM NEFH DES KRT71 VIM KRT9 LMNB2 KRT23 INA LMNA LMNB1 PRPH | 6.95e-16 | 73 | 191 | 15 | PF00038 |
| Domain | IF | KRT72 KRT74 KRT80 NEFM NEFH DES KRT71 VIM KRT9 LMNB2 KRT23 INA LMNA LMNB1 PRPH | 1.32e-15 | 76 | 191 | 15 | IPR001664 |
| Domain | Intermediate_filament_CS | KRT72 KRT74 NEFM NEFH DES KRT71 VIM KRT9 LMNB2 KRT23 INA LMNA LMNB1 PRPH | 2.04e-15 | 63 | 191 | 14 | IPR018039 |
| Domain | Spy1 | 1.66e-14 | 11 | 191 | 8 | PF11357 | |
| Domain | Speedy | 1.66e-14 | 11 | 191 | 8 | IPR020984 | |
| Domain | Filament_head | 2.19e-09 | 7 | 191 | 5 | PF04732 | |
| Domain | Intermed_filament_DNA-bd | 2.19e-09 | 7 | 191 | 5 | IPR006821 | |
| Domain | ACTININ_2 | 9.24e-08 | 23 | 191 | 6 | PS00020 | |
| Domain | ACTININ_1 | 9.24e-08 | 23 | 191 | 6 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.24e-08 | 23 | 191 | 6 | IPR001589 | |
| Domain | Striatin_N | 1.05e-06 | 3 | 191 | 3 | IPR013258 | |
| Domain | Striatin | 1.05e-06 | 3 | 191 | 3 | PF08232 | |
| Domain | ANK | POTEB3 ANKHD1 POTEE CASKIN1 TRPV3 ANKRD18A ANKFY1 TRPA1 POTEF POTEG POTED POTEM POTEI | 1.96e-06 | 251 | 191 | 13 | SM00248 |
| Domain | ANK_REPEAT | POTEB3 ANKHD1 POTEE CASKIN1 TRPV3 ANKRD18A ANKFY1 TRPA1 POTEF POTEG POTED POTEM POTEI | 2.14e-06 | 253 | 191 | 13 | PS50088 |
| Domain | ANK_REP_REGION | POTEB3 ANKHD1 POTEE CASKIN1 TRPV3 ANKRD18A ANKFY1 TRPA1 POTEF POTEG POTED POTEM POTEI | 2.23e-06 | 254 | 191 | 13 | PS50297 |
| Domain | Ankyrin_rpt | POTEB3 ANKHD1 POTEE CASKIN1 TRPV3 ANKRD18A ANKFY1 TRPA1 POTEF POTEG POTED POTEM POTEI | 3.14e-06 | 262 | 191 | 13 | IPR002110 |
| Domain | Ank | ANKHD1 POTEE CASKIN1 TRPV3 ANKRD18A ANKFY1 TRPA1 POTEF POTEG POTED POTEM POTEI | 4.16e-06 | 228 | 191 | 12 | PF00023 |
| Domain | CH | 4.42e-06 | 65 | 191 | 7 | SM00033 | |
| Domain | Keratin_I | 5.40e-06 | 44 | 191 | 6 | IPR002957 | |
| Domain | CH | 7.29e-06 | 70 | 191 | 7 | PF00307 | |
| Domain | - | 8.02e-06 | 71 | 191 | 7 | 1.10.418.10 | |
| Domain | CH | 9.66e-06 | 73 | 191 | 7 | PS50021 | |
| Domain | - | 1.04e-05 | 5 | 191 | 3 | 2.60.40.1260 | |
| Domain | Lamin_tail_dom | 1.04e-05 | 5 | 191 | 3 | IPR001322 | |
| Domain | LTD | 1.04e-05 | 5 | 191 | 3 | PF00932 | |
| Domain | CH-domain | 1.16e-05 | 75 | 191 | 7 | IPR001715 | |
| Domain | Ankyrin_rpt-contain_dom | POTEB3 ANKHD1 POTEE CASKIN1 TRPV3 ANKRD18A ANKFY1 TRPA1 POTEF POTEG POTEM POTEI | 1.24e-05 | 254 | 191 | 12 | IPR020683 |
| Domain | Ank_2 | POTEB3 POTEE CASKIN1 TRPV3 ANKRD18A ANKFY1 TRPA1 POTEF POTEG POTEM POTEI | 1.38e-05 | 215 | 191 | 11 | PF12796 |
| Domain | - | 2.06e-05 | 6 | 191 | 3 | 3.90.1290.10 | |
| Domain | Rho_GTPase_activation_prot | 3.31e-05 | 88 | 191 | 7 | IPR008936 | |
| Domain | Plectin | 3.58e-05 | 7 | 191 | 3 | PF00681 | |
| Domain | Plectin_repeat | 3.58e-05 | 7 | 191 | 3 | IPR001101 | |
| Domain | PLEC | 3.58e-05 | 7 | 191 | 3 | SM00250 | |
| Domain | - | POTEB3 POTEE CASKIN1 TRPV3 ANKRD18A ANKFY1 TRPA1 POTEF POTEG POTEM POTEI | 5.12e-05 | 248 | 191 | 11 | 1.25.40.20 |
| Domain | Plexin_cytopl | 8.45e-05 | 9 | 191 | 3 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 8.45e-05 | 9 | 191 | 3 | IPR013548 | |
| Domain | Plexin | 8.45e-05 | 9 | 191 | 3 | IPR031148 | |
| Domain | Vitellinogen_b-sht_N | 1.04e-04 | 2 | 191 | 2 | IPR015816 | |
| Domain | Lipid_transp_b-sht_shell | 1.04e-04 | 2 | 191 | 2 | IPR015819 | |
| Domain | - | 1.04e-04 | 2 | 191 | 2 | 2.30.230.10 | |
| Domain | VITELLOGENIN | 1.04e-04 | 2 | 191 | 2 | PS51211 | |
| Domain | Lamin_B | 1.04e-04 | 2 | 191 | 2 | IPR027696 | |
| Domain | LPD_N | 1.04e-04 | 2 | 191 | 2 | SM00638 | |
| Domain | Lipid_transpt_N | 1.04e-04 | 2 | 191 | 2 | IPR001747 | |
| Domain | - | 1.04e-04 | 2 | 191 | 2 | 1.25.10.20 | |
| Domain | Vitellogenin_N | 1.04e-04 | 2 | 191 | 2 | PF01347 | |
| Domain | Keratin_II | 1.33e-04 | 26 | 191 | 4 | IPR003054 | |
| Domain | Ion_trans_dom | 1.72e-04 | 114 | 191 | 7 | IPR005821 | |
| Domain | Ion_trans | 1.72e-04 | 114 | 191 | 7 | PF00520 | |
| Domain | IQ | 1.82e-04 | 81 | 191 | 6 | SM00015 | |
| Domain | Spectrin_repeat | 2.06e-04 | 29 | 191 | 4 | IPR002017 | |
| Domain | G-protein_beta_WD-40_rep | 2.37e-04 | 85 | 191 | 6 | IPR020472 | |
| Domain | SPEC | 3.05e-04 | 32 | 191 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.05e-04 | 32 | 191 | 4 | IPR018159 | |
| Domain | Vitellinogen_superhlx | 3.10e-04 | 3 | 191 | 2 | IPR011030 | |
| Domain | - | 3.10e-04 | 3 | 191 | 2 | 4.10.1130.10 | |
| Domain | IQ_motif_EF-hand-BS | 3.23e-04 | 90 | 191 | 6 | IPR000048 | |
| Domain | RasGAP | 3.53e-04 | 14 | 191 | 3 | SM00323 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.53e-04 | 14 | 191 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.53e-04 | 14 | 191 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.53e-04 | 14 | 191 | 3 | IPR013602 | |
| Domain | DHC_N2 | 3.53e-04 | 14 | 191 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.53e-04 | 14 | 191 | 3 | IPR011704 | |
| Domain | MT | 3.53e-04 | 14 | 191 | 3 | PF12777 | |
| Domain | AAA_8 | 3.53e-04 | 14 | 191 | 3 | PF12780 | |
| Domain | RasGAP_CS | 3.53e-04 | 14 | 191 | 3 | IPR023152 | |
| Domain | AAA_5 | 3.53e-04 | 14 | 191 | 3 | PF07728 | |
| Domain | DHC_fam | 4.38e-04 | 15 | 191 | 3 | IPR026983 | |
| Domain | RasGAP | 4.38e-04 | 15 | 191 | 3 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 4.38e-04 | 15 | 191 | 3 | PS00509 | |
| Domain | Dynein_heavy | 4.38e-04 | 15 | 191 | 3 | PF03028 | |
| Domain | RAS_GTPASE_ACTIV_2 | 4.38e-04 | 15 | 191 | 3 | PS50018 | |
| Domain | Dynein_heavy_dom | 4.38e-04 | 15 | 191 | 3 | IPR004273 | |
| Domain | - | 5.34e-04 | 16 | 191 | 3 | 1.10.506.10 | |
| Domain | Actin_CS | 5.34e-04 | 16 | 191 | 3 | IPR004001 | |
| Domain | KASH | 6.16e-04 | 4 | 191 | 2 | IPR012315 | |
| Domain | KASH | 6.16e-04 | 4 | 191 | 2 | PS51049 | |
| Domain | Toprim | 6.16e-04 | 4 | 191 | 2 | PF01751 | |
| Domain | KASH | 6.16e-04 | 4 | 191 | 2 | SM01249 | |
| Domain | KASH | 6.16e-04 | 4 | 191 | 2 | PF10541 | |
| Domain | Toprim_domain | 6.16e-04 | 4 | 191 | 2 | IPR006171 | |
| Domain | TOPRIM | 6.16e-04 | 4 | 191 | 2 | PS50880 | |
| Domain | ACTINS_2 | 6.44e-04 | 17 | 191 | 3 | PS00432 | |
| Domain | Ig_E-set | 7.00e-04 | 104 | 191 | 6 | IPR014756 | |
| Domain | RasGAP_dom | 7.67e-04 | 18 | 191 | 3 | IPR001936 | |
| Domain | Actin/actin-like_CS | 7.67e-04 | 18 | 191 | 3 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 9.04e-04 | 19 | 191 | 3 | PS01132 | |
| Domain | WD40_repeat_CS | 1.51e-03 | 164 | 191 | 7 | IPR019775 | |
| Domain | Spectrin | 1.60e-03 | 23 | 191 | 3 | PF00435 | |
| Domain | Keratin_2_head | 1.82e-03 | 24 | 191 | 3 | IPR032444 | |
| Domain | Keratin_2_head | 1.82e-03 | 24 | 191 | 3 | PF16208 | |
| Domain | SH3_2 | 1.89e-03 | 86 | 191 | 5 | PF07653 | |
| Domain | SH3_2 | 1.89e-03 | 86 | 191 | 5 | IPR011511 | |
| Domain | TF_MADSbox | 2.11e-03 | 7 | 191 | 2 | IPR002100 | |
| Domain | - | FBXW2 STRN STRN4 HERC1 TAF5 WDR17 PLXNA2 PLXNB3 STRN3 PLXNA4 | 2.32e-03 | 333 | 191 | 10 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | FBXW2 STRN STRN4 HERC1 TAF5 WDR17 PLXNA2 PLXNB3 STRN3 PLXNA4 | 2.42e-03 | 335 | 191 | 10 | IPR015943 |
| Domain | IPT | 2.57e-03 | 27 | 191 | 3 | SM00429 | |
| Domain | IQ | 2.67e-03 | 93 | 191 | 5 | PS50096 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 2.36e-05 | 87 | 139 | 7 | MM15351 | |
| Pubmed | KRT72 MYH10 PDE6A MYO1A CCT3 KRT74 RPS6 MCM5 CHD2 CAGE1 NEFM POTEE DES STRN KRT71 SYNE2 VPS13A STRN4 PLEC PPIP5K2 PLXNA2 VIM FLNB FLNC STRN3 MACC1 POTEF SYNE1 IFT81 NUP98 GRIA2 APOB LMNB2 CFAP210 ZFC3H1 PRPF8 KRT23 ERLIN2 INA LMNA LMNB1 PLXNA4 MTTP MACF1 POTEI TOP2B PRPH | 3.32e-22 | 1442 | 203 | 47 | 35575683 | |
| Pubmed | Murine fertility and spermatogenesis are independent of the testis-specific Spdye4a gene. | 7.41e-15 | 9 | 203 | 7 | 36272447 | |
| Pubmed | MYH10 CCT3 NEFM NEFH STRN CASKIN1 SYNE2 STRN4 KCNMA1 TAF5 RASAL2 VIM STRN3 BIN1 MIA3 ANKFY1 CLIP2 SYNE1 DYRK1A FARSB ARHGEF18 GRIA2 LMNB2 ADAM22 INA LMNB1 MACF1 PRKCG CTNNA1 PCM1 | 8.33e-14 | 963 | 203 | 30 | 28671696 | |
| Pubmed | Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins. | 3.47e-13 | 13 | 203 | 7 | 15611625 | |
| Pubmed | CCT3 RPS6 ZZEF1 NEFM NEFH SYNE2 SCN5A PLEC VIM POTEF SYNE1 LMNB2 ZFC3H1 INA PRPH | 3.93e-13 | 187 | 203 | 15 | 26460568 | |
| Pubmed | 3.04e-12 | 9 | 203 | 6 | 7720210 | ||
| Pubmed | ENPP6 KRT72 MYH10 CCT3 RPS6 NEFM NEFH STRN CASKIN1 STRN4 PLEC RASAL2 VIM FLNB FLNC STRN3 BIN1 CLIP2 SYNE1 DYRK1A FARSB GRIA2 ADAM22 MADD ERLIN2 INA LMNA SUGP2 MICAL2 PLXNA4 MACF1 PRKCG CTNNA1 PCM1 | 3.26e-12 | 1431 | 203 | 34 | 37142655 | |
| Pubmed | Characterization of a new family of cyclin-dependent kinase activators. | 3.85e-12 | 17 | 203 | 7 | 15574121 | |
| Pubmed | MYH10 EPPK1 CCT3 RPS6 MCM5 CHD2 ANKHD1 ITPR3 NEFM SYNE2 PLEC FLNB FLNC NUP98 LMNB2 PRPF8 INA LMNA SUGP2 MACF1 CTNNA1 PCM1 | 4.92e-11 | 653 | 203 | 22 | 22586326 | |
| Pubmed | MYH10 ANKHD1 ITPR3 PLEC PPIP5K2 VIM FLNB FLNC MIA3 NUP98 UBA2 LMNB2 DARS2 LMNA DEF6 MACF1 CTNNA1 | 5.14e-11 | 360 | 203 | 17 | 33111431 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CCT3 CHD2 ZZEF1 POTEE FAM20C VPS13A ANKRD18A PLXNB3 DOP1B FLNB DNAH3 KIF26B FAM227B LMNB2 PRPF8 CCDC39 DARS2 LOXHD1 LMNA LMNB1 PLXNA4 FBXO43 SPDYE16 | 7.71e-11 | 736 | 203 | 23 | 29676528 |
| Pubmed | DDX47 EPPK1 CCT3 CENPB MCM5 ITPR3 NEFM POTEE PLEC VIM FLNB POLR2E APOB LMNB2 PRPF8 ARG1 ERLIN2 LMNA LMNB1 TOP2B TOP3A | 3.14e-10 | 652 | 203 | 21 | 31180492 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DDX47 EPPK1 CCT3 RPS6 MCM5 KRT80 ITPR3 SYNE2 PLEC FLNB FLNC SYNE1 POLR2E NUP98 LMNB2 PRPF8 ARG1 INA LMNA LMNB1 SUGP2 MACF1 CTNNA1 TOP2B PCM1 HELLS | 3.71e-10 | 1024 | 203 | 26 | 24711643 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT72 MYH10 EPPK1 CCT3 KRT74 RPS6 ANKHD1 NEFM KCNMA1 PLEC VIM FLNB FLNC STRN3 KRT9 ARG1 LMNA MYO15A PCM1 | 1.10e-09 | 564 | 203 | 19 | 21565611 |
| Pubmed | Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle. | 1.59e-09 | 10 | 203 | 5 | 28533284 | |
| Pubmed | DDX47 MYH10 ORC3 MCM5 KRT80 ITPR3 POTEE PLEC VIM FLNB POLR2E NUP98 LMNB2 PRPF8 ERLIN2 LMNA LMNB1 MACF1 TOP2B PCM1 | 2.40e-09 | 660 | 203 | 20 | 32780723 | |
| Pubmed | HIPK1 NEFM NEFH CASKIN1 STRN4 KCNMA1 PLEC BIN1 CLIP2 ADAM22 MADD MACF1 PRKCG CTNNA1 PCM1 | 2.43e-09 | 347 | 203 | 15 | 17114649 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | MYH10 EPPK1 CCT3 RPS6 MCM5 SCN5A PLEC VIM FLNB FLNC FARSB LMNB2 PRPF8 LMNA LMNB1 SUGP2 PCM1 | 3.73e-09 | 477 | 203 | 17 | 31300519 |
| Pubmed | Distribution of neuronal intermediate filament proteins in the developing mouse olfactory system. | 5.61e-09 | 5 | 203 | 4 | 9819140 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DDX47 MYH10 CCT3 RPS6 MCM5 CHD2 ANKHD1 PLEC RASAL2 VIM FLNB FLNC ANKFY1 DSC3 POLR2E FARSB LMNB2 PRPF8 ARG1 SMG8 LMNA LMNB1 SUGP2 POLR1E MICAL2 MACF1 MAP2K3 TOP2B | 6.85e-09 | 1353 | 203 | 28 | 29467282 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYH10 MYO1A CENPB ORC3 HIPK1 ANKHD1 MEF2C NEFM DES FLNC NRF1 IFT81 NUP98 DYRK1A FARSB LMNB2 PRPF8 DARS2 SUGP2 MAP2K3 TOP2B HELLS | 7.57e-09 | 857 | 203 | 22 | 25609649 |
| Pubmed | 7.92e-09 | 100 | 203 | 9 | 21800051 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH10 EPPK1 CCT3 RPS6 ZZEF1 PLEC VIM FLNB FLNC KRT9 MIA3 SYNE1 PRPF8 EPG5 DNAH1 ERLIN2 LMNA LMNB1 MACF1 CTNNA1 MYO15A | 1.34e-08 | 807 | 203 | 21 | 30575818 |
| Pubmed | 1.67e-08 | 6 | 203 | 4 | 18827015 | ||
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 1.85e-08 | 15 | 203 | 5 | 16824795 | |
| Pubmed | KRT72 MYH10 CCT3 RPS6 MCM5 ANKHD1 NEFH DES KRT71 VIM FLNB POTEF UBA2 PRPF8 MADD INA MACF1 | 2.19e-08 | 538 | 203 | 17 | 28524877 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DDX47 KRT72 MYH10 EPPK1 CCT3 RPS6 MCM5 KRT80 ITPR3 PLEC RASAL2 FLNB KRT9 DSC3 POLR2E NUP98 FARSB LMNB2 ZFC3H1 PRPF8 ARG1 LMNA LMNB1 POLR1E CTNNA1 CDK7 | 2.52e-08 | 1257 | 203 | 26 | 36526897 |
| Pubmed | MYH10 CCT3 HIPK1 MEF2C DES PLEC FLNC CLIP2 KIF26B SYNE1 NUP98 MADD KRT23 HIPK3 MACF1 CTNNA1 | 3.28e-08 | 486 | 203 | 16 | 20936779 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | DDX47 KRT72 CCT3 RPS6 MCM5 KRT80 KRT71 PLEC VIM FLNC KRT9 ANKFY1 DSC3 ARG1 KRT23 ERLIN2 LMNA | 3.71e-08 | 558 | 203 | 17 | 27591049 |
| Pubmed | Math5 is required for retinal ganglion cell and optic nerve formation. | 3.77e-08 | 17 | 203 | 5 | 11493566 | |
| Pubmed | 3.89e-08 | 7 | 203 | 4 | 15276201 | ||
| Pubmed | The cytoskeleton of the myenteric neurons during murine embryonic life. | 3.89e-08 | 7 | 203 | 4 | 10221457 | |
| Pubmed | HIPK1 NEFM NELL1 PLEC WDR17 PLXNB3 RASAL2 DOP1B VIM FLNB BIN1 LURAP1 CLIP2 SYNE1 IFT81 DYRK1A ZFC3H1 IDS PRPF8 BLOC1S2 ADAM22 MADD MICAL2 MACF1 CTNNA1 PCM1 | 3.90e-08 | 1285 | 203 | 26 | 35914814 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | MYH10 MCM5 NEFM SYNE2 PPIP5K2 CUL2 VIM FLNB BIN1 PRPF8 DARS2 INA SUGP2 MACF1 CTNNA1 PRPH | 4.59e-08 | 498 | 203 | 16 | 36634849 |
| Pubmed | 5.23e-08 | 124 | 203 | 9 | 35516420 | ||
| Pubmed | DDX47 MYH10 CCT3 ORC3 RPS6 CASKIN1 PLEC VIM FLNB DNAH3 KRT9 SYNE1 FARSB LMNB2 PRPF8 TG ARG1 INA LMNA LMNB1 | 6.19e-08 | 803 | 203 | 20 | 36517590 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 7.65e-08 | 219 | 203 | 11 | 31353912 | |
| Pubmed | Lamin B1 protein is required for dendrite development in primary mouse cortical neurons. | 7.74e-08 | 8 | 203 | 4 | 26510501 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DDX47 NOL4 MYH10 CHD2 NEFM PLEC PPIP5K2 MED17 VIM FLNC KRT9 SYNE1 ARRDC5 LMNB2 PRPF8 ARG1 INA LMNA LMNB1 SUGP2 MACF1 TOP2B PRPH | 1.06e-07 | 1082 | 203 | 23 | 38697112 |
| Pubmed | 1.39e-07 | 9 | 203 | 4 | 16364570 | ||
| Pubmed | DDX47 CCT3 CENPB ORC3 MCM5 CHD2 PLEC MED17 CUL2 POLR2E NUP98 UBA2 FARSB LMNB2 PRPF8 SUGP2 POLR1E MYO15A MAP2K3 TOP2B CDK7 HELLS | 1.44e-07 | 1014 | 203 | 22 | 32416067 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | MYH10 MYO1A CCT3 POTEE VIM FLNB POTEF INA LMNB1 CTNNA1 POTEI PRPH | 1.49e-07 | 288 | 203 | 12 | 31501420 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.56e-07 | 235 | 203 | 11 | 30258100 | |
| Pubmed | MYH10 CCT3 RPS6 MCM5 NEFM PLEC VIM FLNB FLNC ANKFY1 POLR2E FARSB PRPF8 INA LMNA PRPH | 1.81e-07 | 551 | 203 | 16 | 34728620 | |
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 25312645 | ||
| Pubmed | A- and B-type lamins are differentially expressed in normal human tissues. | 1.96e-07 | 3 | 203 | 3 | 9243284 | |
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 15284226 | ||
| Pubmed | Review: nuclear lamins--structural proteins with fundamental functions. | 1.96e-07 | 3 | 203 | 3 | 10806082 | |
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 28241138 | ||
| Pubmed | Expression of nuclear lamins during mouse preimplantation development. | 1.96e-07 | 3 | 203 | 3 | 3046911 | |
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 10960149 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 20004208 | ||
| Pubmed | MYH10 CCT3 KRT74 RPS6 KRT80 PLEC CUL2 VIM FLNB FLNC KRT9 ERLIN2 LMNA MACF1 CTNNA1 | 2.16e-07 | 488 | 203 | 15 | 31324722 | |
| Pubmed | MYH10 CCT3 KRT74 RPS6 ANKHD1 KRT80 VIM KRT9 NUP98 UBA2 FARSB PRPF8 ARG1 ERLIN2 LMNA LMNB1 TOP2B | 2.65e-07 | 641 | 203 | 17 | 36057605 | |
| Pubmed | 3.60e-07 | 11 | 203 | 4 | 20170731 | ||
| Pubmed | 4.40e-07 | 159 | 203 | 9 | 34537242 | ||
| Pubmed | KRT72 MYH10 CCT3 MCM5 CUL2 VIM STRN3 KRT9 UBA2 FARSB DARS2 THRA LMNA LMNB1 | 4.92e-07 | 451 | 203 | 14 | 36168627 | |
| Pubmed | 5.38e-07 | 12 | 203 | 4 | 28595999 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 5.39e-07 | 212 | 203 | 10 | 33853758 | |
| Pubmed | MYH10 CCT3 RPS6 POTEE FLNB LMNB2 PRPF8 ARG1 ERLIN2 LMNB1 MACF1 TOP2B | 5.78e-07 | 327 | 203 | 12 | 31409639 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 MCM5 ANKHD1 ZZEF1 TPCN1 ITPR3 FAM20C CASKIN1 SCN5A STRN4 PLEC HERC1 FLNC NRF1 DYRK1A LMNB2 MADD PIKFYVE SUGP2 PCNX4 DEF6 TOP3A | 6.14e-07 | 1105 | 203 | 22 | 35748872 |
| Pubmed | 6.44e-07 | 84 | 203 | 7 | 19165527 | ||
| Pubmed | EPPK1 RPS6 IRAK2 TACC1 PLEC DNAH5 FLNB PRPF8 LMNA MACF1 CTNNA1 PCM1 | 6.78e-07 | 332 | 203 | 12 | 37433992 | |
| Pubmed | 7.51e-07 | 54 | 203 | 6 | 35474131 | ||
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 7.70e-07 | 125 | 203 | 8 | 21654808 | |
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 20213320 | ||
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 16648470 | ||
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 16923132 | ||
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 2680424 | ||
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 25869803 | ||
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 10748158 | ||
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 29196434 | ||
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 19457133 | ||
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 30968547 | ||
| Pubmed | LINC complexes mediate the positioning of cone photoreceptor nuclei in mouse retina. | 7.80e-07 | 4 | 203 | 3 | 23071752 | |
| Pubmed | Neurofilament transport in vivo minimally requires hetero-oligomer formation. | 7.80e-07 | 4 | 203 | 3 | 14561875 | |
| Pubmed | Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation. | 7.80e-07 | 4 | 203 | 3 | 34785661 | |
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 12648212 | ||
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 17005864 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DDX47 MYH10 TBRG4 CCT3 ORC3 RPS6 MCM5 CHD2 PLEC TAF5 PPIP5K2 VIM KRT9 POLR2E NUP98 UBA2 FARSB PRPF8 DARS2 LMNA LMNB1 POLR1E MAP2K3 TOP2B | 8.96e-07 | 1318 | 203 | 24 | 30463901 |
| Pubmed | MYH10 HIPK1 CSMD3 NEFH PLXNA2 PLXNB3 DOP1B ANKFY1 SYNE1 MADD EPG5 SUGP2 MACF1 | 9.27e-07 | 407 | 203 | 13 | 12693553 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | DDX47 MYH10 CCT3 RPS6 ITPR3 PLEC VIM FLNB KRT9 PRPF8 KRT23 THRA LMNA LMNB1 TOP3A PCM1 | 9.77e-07 | 626 | 203 | 16 | 33644029 |
| Pubmed | MYH10 RPS6 STRN CASKIN1 STRN4 TACC1 PLEC VIM FLNB STRN3 BIN1 MIA3 GRIA2 ADAM22 MADD ERLIN2 INA LMNA SUGP2 MACF1 PRKCG PCM1 | 1.01e-06 | 1139 | 203 | 22 | 36417873 | |
| Pubmed | Mechanical regulation of glycolysis via cytoskeleton architecture. | 1.08e-06 | 14 | 203 | 4 | 32051585 | |
| Pubmed | 1.32e-06 | 234 | 203 | 10 | 36243803 | ||
| Pubmed | A molecular mechanism underlying the neural-specific defect in torsinA mutant mice. | 1.46e-06 | 15 | 203 | 4 | 20457914 | |
| Pubmed | RPS6 CHD2 DES SYNE2 PLEC FLNB FLNC BIN1 ANKFY1 SYNE1 BLOC1S2 THRA LMNA MACF1 | 1.55e-06 | 497 | 203 | 14 | 23414517 | |
| Pubmed | 1.89e-06 | 63 | 203 | 6 | 16831889 | ||
| Pubmed | Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects? | 1.94e-06 | 5 | 203 | 3 | 11090858 | |
| Pubmed | 1.94e-06 | 5 | 203 | 3 | 9971739 | ||
| Pubmed | 1.94e-06 | 5 | 203 | 3 | 23374351 | ||
| Pubmed | 1.94e-06 | 5 | 203 | 3 | 18502210 | ||
| Pubmed | Reciprocal knock-in mice to investigate the functional redundancy of lamin B1 and lamin B2. | 1.94e-06 | 5 | 203 | 3 | 24672053 | |
| Pubmed | MYH10 EPPK1 PDE6A DES STRN FLNC STRN3 ANKFY1 DSC3 LMNB2 MAP2K3 | 1.97e-06 | 304 | 203 | 11 | 32235678 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DDX47 MYH10 MYO1A CENPB MCM5 STRN STRN4 PLEC CUL2 FLNB FLNC STRN3 ANKFY1 LONP2 POLR2E NUP98 PRPF8 BLOC1S2 ARG1 POLR1E | 2.07e-06 | 1005 | 203 | 20 | 19615732 |
| Pubmed | 2.48e-06 | 251 | 203 | 10 | 27507650 | ||
| Pubmed | 2.53e-06 | 17 | 203 | 4 | 11683995 | ||
| Pubmed | 2.61e-06 | 147 | 203 | 8 | 16959763 | ||
| Pubmed | TBRG4 EPPK1 CCT3 MCM5 NEFM PLEC VIM FLNB FLNC DSC3 SYNE1 FARSB PRPF8 ARG1 LMNA LMNB1 MACF1 CTNNA1 | 2.65e-06 | 844 | 203 | 18 | 25963833 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DDX47 MYH10 TBRG4 EPPK1 CCT3 RPP40 RPS6 MCM5 ANKHD1 SYNE2 PLEC VIM FLNB KRT9 LONP2 POLR2E FARSB PRPF8 DARS2 LMNA MACF1 CTNNA1 TOP2B HELLS | 3.06e-06 | 1415 | 203 | 24 | 28515276 |
| Interaction | KIF20A interactions | DDX47 MYH10 EPPK1 MYO1A CENPB RPS6 MCM5 CHD2 NEFM POTEE DES SYNE2 ANKRD18A PLEC HERC1 VIM FLNB FLNC IFT20 SYNE1 NUP98 DYRK1A APOB LMNB2 CFAP210 PRPF8 INA LMNA LMNB1 SUGP2 MACF1 CCDC171 TOP2B PCM1 PRPH | 1.28e-10 | 1052 | 195 | 35 | int:KIF20A |
| Interaction | KRT16 interactions | KRT72 KRT74 KRT80 NEFM DES KRT71 PLEC CUL2 VIM FSD1 PRPF8 TXLNB INA PCM1 PRPH | 8.81e-10 | 197 | 195 | 15 | int:KRT16 |
| Interaction | GAN interactions | CCT3 RPS6 ZZEF1 NEFM NEFH DES SYNE2 SCN5A PLEC VIM POTEF SYNE1 LMNB2 ZFC3H1 INA PRPH | 3.56e-09 | 253 | 195 | 16 | int:GAN |
| Interaction | CIT interactions | DDX47 MYH10 EPPK1 CCT3 ORC3 HIPK1 RPS6 MCM5 CHD2 ZZEF1 ITPR3 NEFM DES SYNE2 PLEC HERC1 TAF5 RASAL2 VIM FLNB FLNC DSC3 SYNE1 POLR2E NUP98 DYRK1A APOB LMNB2 PRPF8 INA LMNA LMNB1 SUGP2 POTEM MACF1 CTNNA1 TOP2B PRPH | 1.48e-08 | 1450 | 195 | 38 | int:CIT |
| Interaction | OBSL1 interactions | DDX47 EPPK1 CCT3 RPS6 MCM5 ITPR3 POTEE NELL1 SYNE2 PLEC FLNB FLNC SYNE1 POLR2E NUP98 DYRK1A LMNB2 PRPF8 DNAH1 INA LMNA LMNB1 SUGP2 POLR1E MACF1 CTNNA1 TOP2B PCM1 | 4.99e-08 | 902 | 195 | 28 | int:OBSL1 |
| Interaction | INA interactions | KRT72 RPS6 NEFM NEFH DES KCNMA1 PLEC VIM ANKFY1 KRT23 INA PRPH | 1.25e-07 | 173 | 195 | 12 | int:INA |
| Interaction | TNIK interactions | NEFM STRN SYNE2 STRN4 KCNMA1 TAF5 STRN3 BIN1 SYNE1 GRIA2 LMNB2 INA LMNB1 MACF1 PRKCG CTNNA1 PCM1 | 1.93e-07 | 381 | 195 | 17 | int:TNIK |
| Interaction | KRT14 interactions | KRT72 EPPK1 KRT80 NEFM DES PLEC CUL2 VIM PRPF8 INA PCM1 PRPH | 3.88e-07 | 192 | 195 | 12 | int:KRT14 |
| Interaction | KCTD13 interactions | ENPP6 KRT72 MYH10 CCT3 RPS6 NEFM NEFH STRN CASKIN1 STRN4 PLEC RASAL2 VIM FLNB FLNC STRN3 BIN1 CLIP2 SYNE1 DYRK1A FARSB GRIA2 ADAM22 MADD ERLIN2 INA LMNA SUGP2 MICAL2 PLXNA4 MACF1 PRKCG CTNNA1 PCM1 | 5.21e-07 | 1394 | 195 | 34 | int:KCTD13 |
| Interaction | KRT24 interactions | 8.59e-07 | 54 | 195 | 7 | int:KRT24 | |
| Interaction | SIRT7 interactions | MYH10 EPPK1 CCT3 RPS6 MCM5 CHD2 ANKHD1 ITPR3 NEFM SYNE2 PLEC FLNB FLNC NUP98 LMNB2 PRPF8 INA LMNA SUGP2 POLR1E MACF1 CTNNA1 PCM1 | 9.36e-07 | 744 | 195 | 23 | int:SIRT7 |
| Interaction | RNF123 interactions | CCT3 CHD2 ZZEF1 POTEE FAM20C VPS13A ANKRD18A PLXNB3 DOP1B FLNB FLNC DNAH3 KIF26B FAM227B LMNB2 PRPF8 CCDC39 DARS2 LOXHD1 LMNA LMNB1 PLXNA4 FBXO43 SPDYE16 | 1.52e-06 | 824 | 195 | 24 | int:RNF123 |
| Interaction | NEFM interactions | 2.53e-06 | 190 | 195 | 11 | int:NEFM | |
| Interaction | IFT57 interactions | 3.36e-06 | 93 | 195 | 8 | int:IFT57 | |
| Interaction | KRT6A interactions | 3.70e-06 | 160 | 195 | 10 | int:KRT6A | |
| Interaction | SYNC interactions | 3.80e-06 | 67 | 195 | 7 | int:SYNC | |
| Interaction | PLEKHG1 interactions | 3.80e-06 | 67 | 195 | 7 | int:PLEKHG1 | |
| Interaction | KRT19 interactions | KRT72 KRT74 MCM5 KRT80 NEFM DES KRT71 PLEC VIM INA LMNB1 PCM1 PRPH | 3.90e-06 | 282 | 195 | 13 | int:KRT19 |
| Interaction | KRT27 interactions | KRT72 TBRG4 EPPK1 KRT74 NEFM KRT71 CUL2 BLOC1S2 TXLNB INA PRPH | 4.57e-06 | 202 | 195 | 11 | int:KRT27 |
| Interaction | POTEC interactions | 5.68e-06 | 13 | 195 | 4 | int:POTEC | |
| Interaction | SMOX interactions | 5.68e-06 | 13 | 195 | 4 | int:SMOX | |
| Interaction | CCDC8 interactions | EPPK1 CCT3 MCM5 KRT80 ITPR3 PLEC FLNB POLR2E DYRK1A APOB LMNB2 PRPF8 ARG1 LMNA LMNB1 SUGP2 MACF1 CTNNA1 PCM1 HELLS | 6.18e-06 | 656 | 195 | 20 | int:CCDC8 |
| Interaction | KRT8 interactions | KRT72 EPPK1 KRT74 TBC1D2B ITPR3 NEFM DES KRT71 STRN4 PLEC VIM MIA3 PRPF8 KRT23 INA PRPH | 6.53e-06 | 441 | 195 | 16 | int:KRT8 |
| Interaction | KRT84 interactions | 7.52e-06 | 49 | 195 | 6 | int:KRT84 | |
| Interaction | ACTG2 interactions | 7.52e-06 | 49 | 195 | 6 | int:ACTG2 | |
| Interaction | USP53 interactions | 8.09e-06 | 138 | 195 | 9 | int:USP53 | |
| Interaction | CHMP4B interactions | DDX47 MYH10 EPPK1 RPS6 MCM5 ITPR3 POTEE DES PLEC VIM FLNB FLNC BIN1 NUP98 UBA2 PRPF8 INA LMNA LMNB1 PMFBP1 PRPH | 8.17e-06 | 727 | 195 | 21 | int:CHMP4B |
| Interaction | PRC1 interactions | DDX47 MYH10 EPPK1 CCT3 PLCXD1 RPS6 MCM5 ZZEF1 DES KCNMA1 PLEC HERC1 CUL2 VIM FLNB FLNC SYNE1 NUP98 LMNB2 PRPF8 LMNA LMNB1 TOP2B PCM1 PRPH | 8.28e-06 | 973 | 195 | 25 | int:PRC1 |
| Interaction | METTL14 interactions | KRT72 MYH10 CCT3 RPS6 KRT80 PLEC PLG HERC1 WDR17 CUL2 VIM FLNC KRT9 PRPF8 ARG1 LMNA LMNB1 TOP2B | 8.62e-06 | 558 | 195 | 18 | int:METTL14 |
| Interaction | KRT15 interactions | 9.52e-06 | 178 | 195 | 10 | int:KRT15 | |
| Interaction | YWHAZ interactions | MYH10 MEF2C NEFM STRN UCP2 SYNE2 KCNMA1 PLEC PPIP5K2 RASAL2 CUL2 VIM BIN1 DSC3 CLIP2 KIF26B POTEF SAMD4B ARHGEF18 PRPF8 ADAM22 MADD ARG1 PTOV1 INA LMNA MACF1 MAP2K3 PCM1 CDK7 | 1.07e-05 | 1319 | 195 | 30 | int:YWHAZ |
| Interaction | KRT75 interactions | 1.10e-05 | 181 | 195 | 10 | int:KRT75 | |
| Interaction | NUPR1 interactions | DDX47 MYH10 ORC3 MCM5 KRT80 ITPR3 POTEE PLEC VIM FLNB POLR2E NUP98 LMNB2 PRPF8 ERLIN2 LMNA LMNB1 MACF1 TOP2B PCM1 | 1.11e-05 | 683 | 195 | 20 | int:NUPR1 |
| Interaction | CYLD interactions | DDX47 KRT72 MYH10 CCT3 RPS6 MCM5 KRT80 KRT71 PLEC CUL2 VIM FLNC KRT9 ANKFY1 TRPA1 DSC3 DYRK1A GRIA2 ARG1 KRT23 ERLIN2 LMNA PCM1 | 1.20e-05 | 868 | 195 | 23 | int:CYLD |
| Interaction | KRT18 interactions | KRT72 EPPK1 KRT74 MCM5 ITPR3 NEFM DES KRT71 PLEC VIM FLNB PRPF8 INA CTNNA1 PRPH | 1.50e-05 | 419 | 195 | 15 | int:KRT18 |
| Interaction | ECT2 interactions | MYH10 EPPK1 MYO1A RPS6 TBC1D2B POTEE DES STRN PLEC DOP1B VIM FLNB FLNC NUP98 PRPF8 MADD RNF14 ERLIN2 INA LMNA MACF1 TOP2B PRPH | 1.70e-05 | 887 | 195 | 23 | int:ECT2 |
| Interaction | KRT26 interactions | 2.07e-05 | 35 | 195 | 5 | int:KRT26 | |
| Interaction | WHAMMP3 interactions | 2.09e-05 | 119 | 195 | 8 | int:WHAMMP3 | |
| Interaction | KRT72 interactions | 2.24e-05 | 59 | 195 | 6 | int:KRT72 | |
| Interaction | CTTNBP2 interactions | 2.98e-05 | 62 | 195 | 6 | int:CTTNBP2 | |
| Interaction | SEMA5A interactions | 3.03e-05 | 7 | 195 | 3 | int:SEMA5A | |
| Interaction | PINK1 interactions | MYH10 EPPK1 CCT3 RPS6 MCM5 SCN5A PLEC PLG VIM FLNB FLNC DSC3 FARSB LMNB2 PRPF8 LMNA LMNB1 SUGP2 PCM1 | 3.48e-05 | 679 | 195 | 19 | int:PINK1 |
| Interaction | AGR2 interactions | MYH10 EPPK1 CCT3 RPS6 CCDC90B ZZEF1 PLEC VIM FLNB FLNC KRT9 MIA3 NRF1 SYNE1 PRPF8 EPG5 DNAH1 ERLIN2 LMNA LMNB1 MACF1 CTNNA1 MYO15A | 3.80e-05 | 934 | 195 | 23 | int:AGR2 |
| Interaction | SIKE1 interactions | 3.91e-05 | 65 | 195 | 6 | int:SIKE1 | |
| Interaction | KRT38 interactions | 4.67e-05 | 172 | 195 | 9 | int:KRT38 | |
| Interaction | MECP2 interactions | DDX47 NOL4 MYH10 RPP40 RPS6 CHD2 NEFM PLEC PPIP5K2 MED17 VIM FLNC KRT9 SYNE1 ARRDC5 GRIA2 LMNB2 PRPF8 ARG1 INA LMNA LMNB1 SUGP2 MACF1 TOP2B TOP3A CDK7 PRPH | 4.79e-05 | 1287 | 195 | 28 | int:MECP2 |
| Interaction | LOXL2 interactions | MYH10 CCT3 RPS6 TBC1D2B POTEE FLNB LMNB2 IDS PRPF8 ARG1 ERLIN2 LMNB1 MACF1 TOP2B | 4.85e-05 | 410 | 195 | 14 | int:LOXL2 |
| Interaction | ACTG1 interactions | MYO1A CCT3 POTEE KCNMA1 PLEC PLG VIM FLNB BIN1 KIF26B POTEF PRPF8 LMNA CTNNA1 POTEI CDK7 | 4.88e-05 | 520 | 195 | 16 | int:ACTG1 |
| Interaction | KRT37 interactions | 5.34e-05 | 100 | 195 | 7 | int:KRT37 | |
| Interaction | SPDL1 interactions | MYH10 EPPK1 CCT3 NEFM POTEE STRN4 PLEC FLNB FLNC PRPF8 TXLNB PCM1 | 6.03e-05 | 315 | 195 | 12 | int:SPDL1 |
| Interaction | C1orf52 interactions | 6.44e-05 | 44 | 195 | 5 | int:C1orf52 | |
| Interaction | KRT32 interactions | 6.44e-05 | 44 | 195 | 5 | int:KRT32 | |
| Interaction | IFT81 interactions | 6.45e-05 | 71 | 195 | 6 | int:IFT81 | |
| Interaction | ROCK2 interactions | 7.24e-05 | 182 | 195 | 9 | int:ROCK2 | |
| Interaction | CUL7 interactions | DDX47 EPPK1 CCT3 RPS6 SYNE2 PLEC PLXNB3 FLNB KRT9 POLR2E NUP98 APOB LMNB2 ZFC3H1 PRPF8 INA LMNA LMNB1 MACF1 CTNNA1 TOP2B | 7.41e-05 | 845 | 195 | 21 | int:CUL7 |
| Interaction | PLEC interactions | NEFM SYNE2 PLEC PPIP5K2 DNAH5 VIM DNAH3 PRPF8 KRT23 INA LMNB1 FBXO43 MACF1 PRPH | 8.07e-05 | 430 | 195 | 14 | int:PLEC |
| Interaction | YWHAQ interactions | EPPK1 DES UCP2 KCNMA1 ANKRD18A PLEC PLG PPIP5K2 RASAL2 CUL2 VIM KRT9 KIF26B POTEF SAMD4B DYRK1A PRPF8 PTOV1 THRA INA LMNA LMNB1 MACF1 PCM1 CDK7 | 8.21e-05 | 1118 | 195 | 25 | int:YWHAQ |
| Interaction | WDR76 interactions | MYH10 EPPK1 CCT3 ORC3 MCM5 PLEC TAF5 VIM FLNB LMNA LMNB1 CTNNA1 HELLS | 9.62e-05 | 383 | 195 | 13 | int:WDR76 |
| Interaction | NES interactions | 1.19e-04 | 152 | 195 | 8 | int:NES | |
| Interaction | HERC2 interactions | MYH10 KRT80 SYNE2 PLEC HERC1 MED17 ARRDC5 LMNB2 ERLIN2 LMNA LMNB1 MACF1 CTNNA1 TOP3A PCM1 | 1.19e-04 | 503 | 195 | 15 | int:HERC2 |
| Interaction | KRT7 interactions | 1.26e-04 | 80 | 195 | 6 | int:KRT7 | |
| Interaction | ACTB interactions | MYH10 CCT3 RPS6 POTEE VPS13A KCNMA1 PLEC PLG DNAH5 CUL2 FLNB FLNC KIF26B POTEF FAM227B BLOC1S2 PLEKHG6 LMNA LMNB1 MACF1 CTNNA1 POTEI TOP2B PCM1 | 1.32e-04 | 1083 | 195 | 24 | int:ACTB |
| Interaction | TPGS1 interactions | 1.35e-04 | 81 | 195 | 6 | int:TPGS1 | |
| Interaction | KRT13 interactions | 1.37e-04 | 116 | 195 | 7 | int:KRT13 | |
| Interaction | RICTOR interactions | MYH10 CCT3 RPS6 MCM5 ANKHD1 KRT80 STRN STRN4 PLEC VIM FLNB FLNC STRN3 FARSB LMNB2 ARG1 ERLIN2 LMNA SUGP2 | 1.51e-04 | 759 | 195 | 19 | int:RICTOR |
| Interaction | ECT2L interactions | 1.67e-04 | 29 | 195 | 4 | int:ECT2L | |
| Interaction | PRPH interactions | 1.72e-04 | 204 | 195 | 9 | int:PRPH | |
| Interaction | LRRC31 interactions | 1.79e-04 | 205 | 195 | 9 | int:LRRC31 | |
| Interaction | POTEG interactions | 1.84e-04 | 12 | 195 | 3 | int:POTEG | |
| Interaction | IFT80 interactions | 1.91e-04 | 30 | 195 | 4 | int:IFT80 | |
| Interaction | TMT1A interactions | CCDC168 ITPR3 SYNE2 VPS13A TACC1 MIA3 DSC3 SYNE1 NUP98 LMNB2 LMNA LMNB1 | 2.06e-04 | 359 | 195 | 12 | int:TMT1A |
| Interaction | AGAP2 interactions | 2.14e-04 | 210 | 195 | 9 | int:AGAP2 | |
| Interaction | FILIP1 interactions | 2.18e-04 | 31 | 195 | 4 | int:FILIP1 | |
| Interaction | KRT23 interactions | 2.18e-04 | 31 | 195 | 4 | int:KRT23 | |
| Interaction | GOLGA6A interactions | 2.24e-04 | 57 | 195 | 5 | int:GOLGA6A | |
| Interaction | VCAM1 interactions | MYH10 CCT3 RPS6 MCM5 PLEC VIM FLNB FLNC KRT9 FARSB PRPF8 LMNA LMNB1 MACF1 | 2.27e-04 | 475 | 195 | 14 | int:VCAM1 |
| Interaction | KRT39 interactions | 2.64e-04 | 59 | 195 | 5 | int:KRT39 | |
| Interaction | DSCAM interactions | 2.67e-04 | 171 | 195 | 8 | int:DSCAM | |
| Interaction | CALD1 interactions | 2.69e-04 | 265 | 195 | 10 | int:CALD1 | |
| Interaction | IQCB1 interactions | KRT72 MYH10 CCT3 KRT74 IRAK2 NEFM PLEC FLNB FLNC STRN3 KRT9 PCM1 | 2.71e-04 | 370 | 195 | 12 | int:IQCB1 |
| Interaction | RAPGEF5 interactions | 2.86e-04 | 60 | 195 | 5 | int:RAPGEF5 | |
| Interaction | ARHGAP24 interactions | KRT72 MYH10 CCT3 MCM5 CUL2 VIM STRN3 KRT9 UBA2 FARSB DARS2 THRA LMNA LMNB1 | 2.87e-04 | 486 | 195 | 14 | int:ARHGAP24 |
| Interaction | KRT33B interactions | 2.88e-04 | 93 | 195 | 6 | int:KRT33B | |
| Interaction | RHOF interactions | DDX47 EPPK1 MCM5 POTEE VPS13A RASAL2 ANKFY1 DSC3 KIF26B LMNB2 PIKFYVE LMNB1 MACF1 CTNNA1 MAP2K3 TOP2B HELLS | 3.05e-04 | 673 | 195 | 17 | int:RHOF |
| Interaction | GLDC interactions | 3.06e-04 | 321 | 195 | 11 | int:GLDC | |
| Interaction | STIP1 interactions | MYH10 CCT3 MCM5 FAM20C CLCN1 KCNMA1 PLEC SPDYE4 VIM FLNB ANKFY1 NUP98 LMNB2 PRPF8 LMNA LMNB1 SUGP2 FBXO43 PRKCG CTNNA1 TOP2B HELLS | 3.07e-04 | 1006 | 195 | 22 | int:STIP1 |
| Interaction | SLFN11 interactions | MYH10 CCT3 MCM5 POTEE SPDYE4 VIM FLNB POTEF NUP98 LMNB2 LMNA LMNB1 | 3.14e-04 | 376 | 195 | 12 | int:SLFN11 |
| Interaction | WASHC3 interactions | 3.32e-04 | 134 | 195 | 7 | int:WASHC3 | |
| Interaction | TRAF3IP1 interactions | 3.42e-04 | 96 | 195 | 6 | int:TRAF3IP1 | |
| Interaction | MTNR1B interactions | 3.48e-04 | 135 | 195 | 7 | int:MTNR1B | |
| Interaction | KRT25 interactions | 3.52e-04 | 35 | 195 | 4 | int:KRT25 | |
| Interaction | KRT20 interactions | 3.59e-04 | 63 | 195 | 5 | int:KRT20 | |
| Interaction | ATG16L1 interactions | CCT3 TBC1D2B MCM5 CCDC168 ITPR3 STRN STRN4 PLEC HERC1 TAF5 MED17 PLXNA2 IFT20 POLR2E FARSB KRT23 PIKFYVE TXLNB LMNB1 DEF6 CTNNA1 ARHGAP45 TOP2B PCM1 | 3.69e-04 | 1161 | 195 | 24 | int:ATG16L1 |
| Interaction | TUBB4B interactions | CCT3 MCM5 ANKHD1 TACC1 CUL2 CLIP2 POTEF PRPF8 ADAM22 MADD PRKCG CTNNA1 MAP2K3 PCM1 CDK7 | 3.78e-04 | 560 | 195 | 15 | int:TUBB4B |
| Interaction | MEX3A interactions | EPPK1 RPS6 IRAK2 TACC1 PLEC DNAH5 FLNB PRPF8 LMNA MACF1 CTNNA1 PCM1 | 3.79e-04 | 384 | 195 | 12 | int:MEX3A |
| Interaction | CDC73 interactions | 3.97e-04 | 386 | 195 | 12 | int:CDC73 | |
| Interaction | USP7 interactions | POTEB3 CENPB RPS6 MCM5 TACC1 PLEC HERC1 DNAH5 SPDYE4 VIM TRPA1 NRF1 SYNE1 POTEG NUP98 DYRK1A IDS PRPF8 S1PR1 LMNA LMNB1 PLXNA4 MACF1 MAP2K3 TOP2B PRPH | 4.01e-04 | 1313 | 195 | 26 | int:USP7 |
| Interaction | CCHCR1 interactions | 4.05e-04 | 229 | 195 | 9 | int:CCHCR1 | |
| Interaction | ZNF550 interactions | 4.16e-04 | 65 | 195 | 5 | int:ZNF550 | |
| Interaction | SIRT6 interactions | DDX47 ORC3 MCM5 ITPR3 MED17 VIM FLNB MIA3 NUP98 DYRK1A ZFC3H1 PRPF8 SMG8 LMNA MAP2K3 TOP2B | 4.19e-04 | 628 | 195 | 16 | int:SIRT6 |
| Cytoband | 7q22.1 | 1.53e-04 | 113 | 203 | 5 | 7q22.1 | |
| Cytoband | 12q24.13 | 1.82e-04 | 25 | 203 | 3 | 12q24.13 | |
| Cytoband | 12q13.13 | 2.29e-04 | 67 | 203 | 4 | 12q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 4.55e-04 | 219 | 203 | 6 | chr7q22 | |
| Cytoband | 19p13.3 | 6.88e-04 | 237 | 203 | 6 | 19p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q32 | 9.33e-04 | 97 | 203 | 4 | chr7q32 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 1.80e-10 | 12 | 141 | 6 | 756 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 3.32e-10 | 13 | 141 | 6 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | ANKHD1 ANKRD18B POTEE CASKIN1 TRPV3 ANKRD18A ANKFY1 TRPA1 POTEF POTEG POTED POTEM POTEI | 5.57e-08 | 242 | 141 | 13 | 403 |
| GeneFamily | Lamins | 4.64e-07 | 3 | 141 | 3 | 612 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 4.53e-06 | 15 | 141 | 4 | 696 | |
| GeneFamily | Intermediate filaments Type III | 4.59e-06 | 5 | 141 | 3 | 610 | |
| GeneFamily | Intermediate filaments Type IV | 9.13e-06 | 6 | 141 | 3 | 611 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.53e-05 | 8 | 141 | 3 | 939 | |
| GeneFamily | Plexins | 3.77e-05 | 9 | 141 | 3 | 683 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 5.35e-05 | 10 | 141 | 3 | 830 | |
| GeneFamily | Keratins, type II | 5.41e-05 | 27 | 141 | 4 | 609 | |
| GeneFamily | Dyneins, axonemal | 2.91e-04 | 17 | 141 | 3 | 536 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 3.59e-04 | 4 | 141 | 2 | 1252 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 4.80e-04 | 20 | 141 | 3 | 1371 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 8.33e-04 | 24 | 141 | 3 | 615 | |
| GeneFamily | Topoisomerases | 8.87e-04 | 6 | 141 | 2 | 1050 | |
| GeneFamily | Mannosyl-glycoprotein N-acetylglucosaminyltransferases | 2.10e-03 | 9 | 141 | 2 | 435 | |
| GeneFamily | Chloride voltage-gated channels | 2.61e-03 | 10 | 141 | 2 | 302 | |
| GeneFamily | WD repeat domain containing | 4.52e-03 | 262 | 141 | 7 | 362 | |
| GeneFamily | DNA helicases | 7.61e-03 | 17 | 141 | 2 | 1167 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class II | 9.47e-03 | 19 | 141 | 2 | 132 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | TSNAXIP1 CCDC60 IQCD KRT80 CFAP54 DNAH5 DNAH3 CFAP210 SLC9C2 DNAH1 ARG1 KRT23 | 1.33e-10 | 200 | 201 | 12 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | TSNAXIP1 CCDC60 IQCD KRT80 CFAP54 DNAH5 DNAH3 CFAP210 SLC9C2 DNAH1 ARG1 KRT23 | 1.33e-10 | 200 | 201 | 12 | da12821e8a0657869ca0f75d351cce2d7605a505 |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | TSNAXIP1 CCDC60 KRT80 CFAP54 DNAH5 DNAH3 CFAP210 CCDC39 DNAH1 ARG1 KRT23 | 1.80e-09 | 198 | 201 | 11 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | TSNAXIP1 CCDC60 KRT80 CFAP54 DNAH5 DNAH3 CFAP210 CCDC39 DNAH1 ARG1 KRT23 | 1.80e-09 | 198 | 201 | 11 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TSNAXIP1 ANKRD18B CFAP54 ANKRD18A DNAH5 DNAH3 SYNE1 IFT81 CFAP210 CCDC39 | 2.04e-08 | 194 | 201 | 10 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MYH10 CSMD3 MEF2C KCNMA1 RASAL2 SYNE1 GRIA2 IDS ADAM22 MICAL2 | 2.47e-08 | 198 | 201 | 10 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | TSNAXIP1 CCDC60 IQCD CFAP54 DNAH5 DNAH3 CFAP210 SLC9C2 CCDC39 DNAH1 | 2.72e-08 | 200 | 201 | 10 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TSNAXIP1 CCDC60 IQCD CFAP54 DNAH5 DNAH3 CFAP210 SLC9C2 DNAH1 | 3.79e-08 | 155 | 201 | 9 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TSNAXIP1 CCDC60 IQCD CFAP54 DNAH5 DNAH3 CFAP210 SLC9C2 DNAH1 | 3.79e-08 | 155 | 201 | 9 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.83e-08 | 171 | 201 | 9 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | TSNAXIP1 CCDC60 IQCD CFAP54 DNAH5 DNAH3 CFAP210 CCDC39 DNAH1 | 2.70e-07 | 195 | 201 | 9 | 60067b5359174f0d1a8b5748bfc0690762e9e740 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-07 | 196 | 201 | 9 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.94e-07 | 197 | 201 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TSNAXIP1 CFAP54 SYNE2 DNAH5 DNAH3 SYNE1 CFAP210 SLC9C2 CCDC39 | 2.94e-07 | 197 | 201 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 3.07e-07 | 198 | 201 | 9 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | TSNAXIP1 CCDC60 IQCD CFAP54 DNAH5 DNAH3 CFAP210 CCDC39 DNAH1 | 3.07e-07 | 198 | 201 | 9 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.07e-07 | 198 | 201 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.07e-07 | 198 | 201 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 3.07e-07 | 198 | 201 | 9 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | TSNAXIP1 CCDC60 CFAP54 DNAH5 DNAH3 MMS22L CFAP210 CCDC39 DNAH1 | 3.20e-07 | 199 | 201 | 9 | 15f7814b7074170eee7ccacaa670b1d128fc68bb |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.20e-07 | 199 | 201 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | TSNAXIP1 IQCD ANKRD18B CFAP54 ANKRD18A DNAH5 DNAH3 SYNE1 CFAP210 | 3.34e-07 | 200 | 201 | 9 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | TSNAXIP1 CCDC60 IQCD CFAP54 DNAH5 DNAH3 CFAP210 CCDC39 DNAH1 | 3.34e-07 | 200 | 201 | 9 | 4992dbf0514d674017315dbd20d91dfec0c608e9 |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.81e-06 | 182 | 201 | 8 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-06 | 184 | 201 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-06 | 184 | 201 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-06 | 184 | 201 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.31e-06 | 188 | 201 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.70e-06 | 192 | 201 | 8 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 193 | 201 | 8 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.81e-06 | 193 | 201 | 8 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 193 | 201 | 8 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 193 | 201 | 8 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.15e-06 | 196 | 201 | 8 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-06 | 197 | 201 | 8 | aafe279b14cdcb786bc45524bc3c26261128ee48 | |
| ToppCell | CV-Moderate|CV / Virus stimulation, Condition and Cluster | 3.27e-06 | 197 | 201 | 8 | 8747a57ded96175a8365f066101ce2af80c8081d | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-06 | 197 | 201 | 8 | fb14da600f563273059a4683a5079af81aca0886 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.39e-06 | 198 | 201 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 3.52e-06 | 199 | 201 | 8 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.66e-06 | 200 | 201 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.52e-06 | 154 | 201 | 7 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.52e-06 | 154 | 201 | 7 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-05 | 169 | 201 | 7 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.61e-05 | 177 | 201 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-05 | 181 | 201 | 7 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-05 | 181 | 201 | 7 | a4e891603645f694687e68e585744ddc1a3c8697 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.93e-05 | 182 | 201 | 7 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.93e-05 | 182 | 201 | 7 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | Immune_cells-large_pre-B.|World / Lineage and Cell class | 2.00e-05 | 183 | 201 | 7 | 81b5ed6ed661d2d6a9b807fefd2f0d59bd4ea77e | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.15e-05 | 185 | 201 | 7 | d51342a3979bd728a80e04126059a3fd8a0dbe3b | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.15e-05 | 185 | 201 | 7 | ef996f4cdbc3971c6c0460d13df64b075ab22154 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-05 | 186 | 201 | 7 | 5ab43a298d23238b34e898d11decf0ad81d1b14e | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.22e-05 | 186 | 201 | 7 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-05 | 186 | 201 | 7 | 740fd06bcd3b24e6ff2ecf8080f378afc3e95084 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.30e-05 | 187 | 201 | 7 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 2.38e-05 | 188 | 201 | 7 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.38e-05 | 188 | 201 | 7 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.46e-05 | 189 | 201 | 7 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-05 | 189 | 201 | 7 | 99b01893da9f9f7c9528afaffad178285211738b | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.55e-05 | 190 | 201 | 7 | b5c6f3248c0c2f648e1578457c6a729ca22bf0da | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.63e-05 | 191 | 201 | 7 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.72e-05 | 192 | 201 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.72e-05 | 192 | 201 | 7 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.81e-05 | 193 | 201 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.81e-05 | 193 | 201 | 7 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.81e-05 | 193 | 201 | 7 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 194 | 201 | 7 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 194 | 201 | 7 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.01e-05 | 195 | 201 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.11e-05 | 196 | 201 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.11e-05 | 196 | 201 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.21e-05 | 197 | 201 | 7 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.21e-05 | 197 | 201 | 7 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-05 | 197 | 201 | 7 | 02e70768a917c5f097bc653e9e965a1000289d2e | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-05 | 197 | 201 | 7 | 8b3bf5b45e49bf1c60e4d2703b470bb890385f67 | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.21e-05 | 197 | 201 | 7 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-05 | 197 | 201 | 7 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | CV-Severe-2|Severe / Virus stimulation, Condition and Cluster | 3.31e-05 | 198 | 201 | 7 | 254659bb53dc2511c714295c2df1ab1fddb2f867 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.31e-05 | 198 | 201 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.31e-05 | 198 | 201 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 3.42e-05 | 199 | 201 | 7 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 3.42e-05 | 199 | 201 | 7 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.42e-05 | 199 | 201 | 7 | 77b4aa00f14b86ef5db0490be98787e063979541 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.42e-05 | 199 | 201 | 7 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.42e-05 | 199 | 201 | 7 | 5de2a32bc2e9c752eb19a013b1807949153728fc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 3.42e-05 | 199 | 201 | 7 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.53e-05 | 200 | 201 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.53e-05 | 200 | 201 | 7 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | Biopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 3.53e-05 | 200 | 201 | 7 | bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.53e-05 | 200 | 201 | 7 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.53e-05 | 200 | 201 | 7 | 74ceebee9af63f8b3ec5857eff1b662752bc3862 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.53e-05 | 200 | 201 | 7 | 1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.53e-05 | 200 | 201 | 7 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 200 | 201 | 7 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.53e-05 | 200 | 201 | 7 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.53e-05 | 200 | 201 | 7 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 200 | 201 | 7 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_ciliated|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.21e-05 | 140 | 201 | 6 | e4689232c473d239b07a7fbcaaa3414fbd9badea | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.21e-05 | 140 | 201 | 6 | 8abbd5dc799943b49cd0045d0da405c3f3d0db6b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.74e-05 | 148 | 201 | 6 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| Drug | NSC34533 | 1.72e-08 | 54 | 193 | 8 | CID000003512 | |
| Drug | diethylene glycol distearate | 6.10e-07 | 9 | 193 | 4 | CID000061026 | |
| Drug | 1-azidopyrene | 6.10e-07 | 9 | 193 | 4 | CID000115167 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | STRN SYNE2 TACC1 HERC1 RASAL2 CUL2 FLNB ANKFY1 PIKFYVE MICAL2 MACF1 | 7.48e-07 | 191 | 193 | 11 | 4168_DN |
| Drug | DKMP | 2.38e-06 | 4 | 193 | 3 | CID003066999 | |
| Drug | mant-GTP | 4.00e-06 | 50 | 193 | 6 | CID000128647 | |
| Drug | 1-phenylpentan-3-amine | 4.18e-06 | 29 | 193 | 5 | CID005195771 | |
| Drug | AC1LA6KT | 4.50e-06 | 51 | 193 | 6 | CID000508110 | |
| Drug | methyl 9-octadecenoate | 5.17e-06 | 112 | 193 | 8 | CID000008202 | |
| Drug | Raney Ni | 5.92e-06 | 5 | 193 | 3 | CID006336846 | |
| Drug | plakin | 6.27e-06 | 82 | 193 | 7 | CID000018752 | |
| Drug | Aapfcmk | 6.35e-06 | 15 | 193 | 4 | CID005487540 | |
| Drug | Dimenhydrinate [523-87-5]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 7.75e-06 | 198 | 193 | 10 | 7431_UP | |
| Drug | intoplicine | 1.18e-05 | 6 | 193 | 3 | CID000065954 | |
| Drug | perchlorate | 1.83e-05 | 133 | 193 | 8 | ctd:C494474 | |
| Drug | dihydroperillic acid | 2.05e-05 | 7 | 193 | 3 | CID000381256 | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.41e-05 | 180 | 193 | 9 | 2859_DN | |
| Drug | C-cluster | 2.52e-05 | 139 | 193 | 8 | CID000446537 | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 3.39e-05 | 188 | 193 | 9 | 4845_DN | |
| Drug | A805480 | 3.45e-05 | 44 | 193 | 5 | CID000620368 | |
| Drug | Terfenadine [50679-08-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 3.84e-05 | 191 | 193 | 9 | 2227_DN | |
| Drug | digalactosyldiacylglycerol (DGDG | 3.91e-05 | 23 | 193 | 4 | CID000447899 | |
| Drug | AC1L9MJT | 4.00e-05 | 192 | 193 | 9 | CID000448959 | |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 5.08e-05 | 198 | 193 | 9 | 7437_UP | |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 5.08e-05 | 198 | 193 | 9 | 1510_DN | |
| Drug | Sudan II | 5.11e-05 | 113 | 193 | 7 | CID005354447 | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; HL60; HT_HG-U133A | 5.28e-05 | 199 | 193 | 9 | 2449_UP | |
| Drug | Isopropamide iodide [71-81-8]; Down 200; 8.4uM; PC3; HT_HG-U133A | 5.28e-05 | 199 | 193 | 9 | 7133_DN | |
| Drug | AC1NSWD2 | 7.15e-05 | 2 | 193 | 2 | CID005318091 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 5.46e-09 | 12 | 176 | 5 | DOID:11726 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 1.43e-08 | 48 | 176 | 7 | DOID:423 (implicated_via_orthology) | |
| Disease | autosomal recessive Emery-Dreifuss muscular dystrophy 3 (implicated_via_orthology) | 2.09e-07 | 3 | 176 | 3 | DOID:0070248 (implicated_via_orthology) | |
| Disease | congenital muscular dystrophy due to LMNA mutation (implicated_via_orthology) | 2.09e-07 | 3 | 176 | 3 | DOID:0110640 (implicated_via_orthology) | |
| Disease | familial partial lipodystrophy type 2 (implicated_via_orthology) | 2.09e-07 | 3 | 176 | 3 | DOID:0070202 (implicated_via_orthology) | |
| Disease | autosomal dominant Emery-Dreifuss muscular dystrophy 2 (implicated_via_orthology) | 2.09e-07 | 3 | 176 | 3 | DOID:0070247 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1A (implicated_via_orthology) | 8.31e-07 | 4 | 176 | 3 | DOID:0110425 (implicated_via_orthology) | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 8.31e-07 | 4 | 176 | 3 | cv:CN293514 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 2.07e-06 | 5 | 176 | 3 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 2.07e-06 | 5 | 176 | 3 | C0410190 | |
| Disease | Emery-Dreifuss muscular dystrophy | 4.12e-06 | 6 | 176 | 3 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 4.12e-06 | 6 | 176 | 3 | C0410189 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 4.12e-06 | 6 | 176 | 3 | DOID:0050557 (implicated_via_orthology) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 7.17e-06 | 7 | 176 | 3 | C0751337 | |
| Disease | progeria (implicated_via_orthology) | 1.14e-05 | 8 | 176 | 3 | DOID:3911 (implicated_via_orthology) | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 7.24e-05 | 14 | 176 | 3 | DOID:0050328 (implicated_via_orthology) | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.06e-04 | 3 | 176 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.06e-04 | 3 | 176 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | ischemic cardiomyopathy | 1.06e-04 | 3 | 176 | 2 | EFO_0001425 | |
| Disease | Amyotrophic Lateral Sclerosis, Familial | 1.94e-04 | 48 | 176 | 4 | C4551993 | |
| Disease | Amyotrophic Lateral Sclerosis, Sporadic | 1.94e-04 | 48 | 176 | 4 | C1862941 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.07e-04 | 200 | 176 | 7 | EFO_0004611, EFO_0020945 | |
| Disease | amyotrophic lateral sclerosis type 1 (is_implicated_in) | 2.11e-04 | 4 | 176 | 2 | DOID:0060193 (is_implicated_in) | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 2.11e-04 | 4 | 176 | 2 | 105400 | |
| Disease | Amyotrophic lateral sclerosis type 1 | 2.11e-04 | 4 | 176 | 2 | cv:C1862939 | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 2.27e-04 | 50 | 176 | 4 | C1862939 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 2.56e-04 | 21 | 176 | 3 | DOID:9884 (implicated_via_orthology) | |
| Disease | mean fractional anisotropy measurement | 2.68e-04 | 95 | 176 | 5 | EFO_0008399 | |
| Disease | resting heart rate | 2.81e-04 | 149 | 176 | 6 | EFO_0004351 | |
| Disease | corpus callosum volume measurement | 3.40e-04 | 100 | 176 | 5 | EFO_0010299 | |
| Disease | Woolly hair, congenital | 3.50e-04 | 5 | 176 | 2 | C0345427 | |
| Disease | alopecia (implicated_via_orthology) | 3.50e-04 | 5 | 176 | 2 | DOID:987 (implicated_via_orthology) | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 4.12e-04 | 224 | 176 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | hippocampal volume | 4.33e-04 | 297 | 176 | 8 | EFO_0005035 | |
| Disease | Limb-girdle muscular dystrophy | 4.90e-04 | 26 | 176 | 3 | cv:C0686353 | |
| Disease | restrictive cardiomyopathy (is_implicated_in) | 5.22e-04 | 6 | 176 | 2 | DOID:397 (is_implicated_in) | |
| Disease | glucagon measurement, glucose tolerance test | 5.22e-04 | 6 | 176 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | Hypotrichosis | 5.22e-04 | 6 | 176 | 2 | C0020678 | |
| Disease | Myofibrillar myopathy | 5.22e-04 | 6 | 176 | 2 | cv:C2678065 | |
| Disease | ceramide measurement | 5.48e-04 | 235 | 176 | 7 | EFO_0010222 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 5.49e-04 | 111 | 176 | 5 | EFO_0004530, EFO_0008595 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 5.49e-04 | 27 | 176 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | corpus callosum mid-anterior volume measurement | 5.49e-04 | 27 | 176 | 3 | EFO_0010297 | |
| Disease | Wooly hair | 7.28e-04 | 7 | 176 | 2 | C0343073 | |
| Disease | Primary familial dilated cardiomyopathy | 7.52e-04 | 30 | 176 | 3 | cv:C0340427 | |
| Disease | PR interval | NELL1 STRN SYNE2 SCN5A PLEC ARRDC5 LMNB2 ADAM22 MICAL2 MACF1 | 8.21e-04 | 495 | 176 | 10 | EFO_0004462 |
| Disease | Muscular Dystrophies, Limb-Girdle | 9.11e-04 | 32 | 176 | 3 | C0686353 | |
| Disease | NRF2 measurement | 9.67e-04 | 8 | 176 | 2 | EFO_0009794 | |
| Disease | Primary dilated cardiomyopathy | 1.09e-03 | 34 | 176 | 3 | cv:C0007193 | |
| Disease | cortical surface area measurement | MYH10 SIDT1 MEF2C NELL1 STRN CLCN2 TACC1 TAF5 PLXNA2 FLNB STRN3 IFT22 KIF26B S1PR1 TG ARG1 INA MACF1 | 1.18e-03 | 1345 | 176 | 18 | EFO_0010736 |
| Disease | leukodystrophy (implicated_via_orthology) | 1.24e-03 | 9 | 176 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | Primary ciliary dyskinesia | 1.29e-03 | 36 | 176 | 3 | cv:C0008780 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.54e-03 | 10 | 176 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.54e-03 | 10 | 176 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 1.54e-03 | 10 | 176 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 1.54e-03 | 10 | 176 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 1.54e-03 | 10 | 176 | 2 | cv:C5675009 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.76e-03 | 144 | 176 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | Tachycardia, Ventricular | 1.88e-03 | 11 | 176 | 2 | C0042514 | |
| Disease | cytochrome p450 3a4 measurement | 1.88e-03 | 11 | 176 | 2 | EFO_0020303 | |
| Disease | clinical treatment | 1.88e-03 | 41 | 176 | 3 | EFO_0007056 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.24e-03 | 12 | 176 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 2.24e-03 | 12 | 176 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | anxiety | 2.27e-03 | 223 | 176 | 6 | EFO_0005230 | |
| Disease | Paroxysmal atrial fibrillation | 2.49e-03 | 156 | 176 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 2.49e-03 | 156 | 176 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.49e-03 | 156 | 176 | 5 | C2585653 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.60e-03 | 229 | 176 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | hypothyroidism (implicated_via_orthology) | 2.64e-03 | 13 | 176 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | Atrial Fibrillation | 2.78e-03 | 160 | 176 | 5 | C0004238 | |
| Disease | Primary Ciliary Dyskinesia | 2.79e-03 | 47 | 176 | 3 | C4551720 | |
| Disease | Cardiomyopathy | 2.79e-03 | 47 | 176 | 3 | cv:C0878544 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 3.07e-03 | 14 | 176 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 3.07e-03 | 14 | 176 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 3.20e-03 | 239 | 176 | 6 | EFO_0010934 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.48e-03 | 243 | 176 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | Nephrosis | 3.53e-03 | 15 | 176 | 2 | C0027720 | |
| Disease | Down syndrome (implicated_via_orthology) | 3.53e-03 | 15 | 176 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 3.66e-03 | 105 | 176 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | susceptibility to bacterial meningitis measurement | 3.72e-03 | 52 | 176 | 3 | EFO_0008411 | |
| Disease | cochlin measurement | 4.02e-03 | 16 | 176 | 2 | EFO_0801481 | |
| Disease | thyroid volume | 4.02e-03 | 16 | 176 | 2 | EFO_0004865 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 4.02e-03 | 16 | 176 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | plasminogen activator inhibitor 1 measurement | 4.14e-03 | 54 | 176 | 3 | EFO_0004792 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 4.32e-03 | 110 | 176 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | Amyotrophic lateral sclerosis | 4.54e-03 | 17 | 176 | 2 | cv:C0002736 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 4.54e-03 | 17 | 176 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 4.54e-03 | 17 | 176 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 4.54e-03 | 17 | 176 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 4.54e-03 | 17 | 176 | 2 | C0751780 | |
| Disease | May-White Syndrome | 4.54e-03 | 17 | 176 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 4.54e-03 | 17 | 176 | 2 | C0751781 | |
| Disease | spinal stenosis | 4.54e-03 | 17 | 176 | 2 | EFO_0007490 | |
| Disease | triglycerides in LDL measurement | 4.59e-03 | 56 | 176 | 3 | EFO_0022320 | |
| Disease | fatty acid measurement | 4.81e-03 | 436 | 176 | 8 | EFO_0005110 | |
| Disease | Congenital Fiber Type Disproportion | 5.08e-03 | 18 | 176 | 2 | C0546264 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 5.08e-03 | 18 | 176 | 2 | C0751779 | |
| Disease | Malignant neoplasm of breast | RPS6 DES CLCN1 SYNE2 RASAL2 VIM FLNB DSC3 SYNE1 NUP98 EPG5 INA MACF1 CYB5R4 | 5.22e-03 | 1074 | 176 | 14 | C0006142 |
| Disease | forced expiratory volume, response to bronchodilator | 5.43e-03 | 445 | 176 | 8 | EFO_0004314, GO_0097366 | |
| Disease | triglycerides to total lipids in large HDL percentage | 5.56e-03 | 60 | 176 | 3 | EFO_0022330 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LEMRKIVAEYEKTIA | 636 | O75410 | |
| AKRYVDQKFVLMLLE | 186 | Q15173 | |
| KLTSLKYLEMKDIAI | 71 | Q6QNY1 | |
| LLIMESKLKEYSLIL | 81 | Q96M60 | |
| RALKYLVMDEADRIL | 166 | Q9H0S4 | |
| IILAKESYAELIMKL | 2176 | Q9HCE0 | |
| ESYAELIMKLLKVSA | 2181 | Q9HCE0 | |
| EMKYLLQKTDRRIEV | 496 | Q76B58 | |
| LKIMLKVYSRALQEE | 466 | Q6ZSZ5 | |
| DLLKMLISSEYSRAK | 1846 | Q96N23 | |
| LILVGYISVKVMLKS | 221 | A8MXV6 | |
| LTEMAYSLLKSEALK | 211 | Q8IZ81 | |
| LYLEKRVKELQMKIT | 331 | Q8TC20 | |
| MLKEELYAIKNDSLR | 336 | Q8IVF6 | |
| KSQEARLMLRIYLIK | 3546 | Q7Z407 | |
| RIMSILDEAIYKVEL | 51 | Q96DY2 | |
| KMALDIEIAAYRKLL | 386 | Q16352 | |
| YDLLMKEKSRLEKTL | 166 | Q6TFL3 | |
| IYKDQLKTRIVLVAM | 276 | Q9P0K1 | |
| RDIAMLKEELYAIKN | 341 | A2A2Z9 | |
| ISLAEKKMLDYERLQ | 756 | Q9UDT6 | |
| VADYLKFKDLILRML | 446 | Q13627 | |
| FKDMDYSRIIERLLK | 311 | O75907 | |
| KTLMESNKLETIRYL | 221 | Q9GZT6 | |
| VMEETLSYLLGRKKR | 211 | P05089 | |
| YMDKEIINLKKDLIR | 41 | Q8IWA6 | |
| EKLKNRYEILTVVML | 636 | Q9UFE4 | |
| MAKRSSLYIRIVEGK | 1 | O43374 | |
| LMIYSLRNKDVKEAL | 286 | Q8NH87 | |
| MAKRSSLYIRIVEGK | 1 | C9J798 | |
| NYKVIKSELDRLRTM | 1106 | Q14573 | |
| VAKLEKHLMLLRQEY | 6 | Q9P2R3 | |
| YSLRIEAMVLKKEFL | 251 | Q9C0D6 | |
| AIYNEDKLMAKALLL | 246 | A5A3E0 | |
| MLAVRKLAELQKAEY | 596 | Q8WXD9 | |
| AMKEYESKSLEELRL | 191 | P52948 | |
| YTLRNKDIMVALRKL | 281 | Q8NH19 | |
| LMELLKSRDYEREIK | 771 | Q9NRZ9 | |
| KLALDMEIHAYRKLL | 366 | P02545 | |
| MKDLISYLEKRTTLE | 296 | Q92619 | |
| MEKLKKRVLEYLAVR | 346 | Q86WA8 | |
| VEISRKVYKGMLDLL | 1001 | Q8WXG6 | |
| RKMVELVHFLLLKYR | 111 | P43356 | |
| LKLLMIAIEYKSANR | 626 | Q12791 | |
| AKRKLMENILLYKEE | 601 | O43187 | |
| AEAAEKLKNRYIIMR | 576 | P33992 | |
| VMTAYDLKKTLAVLL | 76 | Q09328 | |
| EYSLLLSIKMRLEKE | 436 | P35527 | |
| KTEATKLILRYLAAM | 1321 | Q9UKN7 | |
| VIELLTKMYRAVLDA | 976 | Q9UBC5 | |
| ADRREYIDLLKKMLT | 486 | Q86Z02 | |
| YIDLLKKMLTIDADK | 491 | Q86Z02 | |
| EKEYMKQLVKLTRLL | 846 | Q6ZRQ5 | |
| LMKIKQDRASRTYEL | 66 | Q9BTV5 | |
| KLALDMEINAYRKLL | 381 | Q03252 | |
| REHILAKKRMYLLVQ | 141 | A6NEK1 | |
| SLALVIEDKMKRYKS | 826 | Q9Y3R5 | |
| PYKESKLAMLLRESL | 751 | Q2KJY2 | |
| LADLERAQAMIYKLV | 2586 | Q15751 | |
| LKSLESFVELMKTIY | 206 | Q6KB66 | |
| LIERQLYEMVSLRKK | 406 | Q8IVV2 | |
| VKLALDMEISAYRKL | 366 | P20700 | |
| MYRSLFQDLELKKER | 191 | P42262 | |
| IALLEVLSQKRMYRK | 51 | O75369 | |
| LKLTIYSEADLRKKM | 1971 | Q15154 | |
| LALKAFRYTLKLMID | 1021 | Q63HM2 | |
| KMVSEIYLTRLLATK | 1671 | O75051 | |
| KMVSEIYLTRLLATK | 1671 | Q9HCM2 | |
| KAIPEIYLTRLLSMK | 1686 | Q9ULL4 | |
| MLVDFLSAKKIISYR | 81 | Q8NGD1 | |
| LEKAEKKEDTRMYLL | 461 | P55157 | |
| KMALDIEIATYRKLL | 386 | P41219 | |
| IIATDLALYFKKRTM | 666 | P16499 | |
| IALLEVLSQKRMYRK | 71 | Q14315 | |
| VRKYKSMILEDLESA | 156 | Q16656 | |
| MQKLLLEYKARLEDS | 1021 | Q9UJF2 | |
| YLEKVRALEEANMKL | 86 | Q9C075 | |
| ALKMELAYLRAIDVK | 61 | Q96LR2 | |
| KYRKINEDIDLMISR | 116 | Q06413 | |
| IIYRDLKLDNVMLDA | 476 | P05129 | |
| VLYDVLSIVRDKKFM | 111 | Q9NVC6 | |
| REFVSLLKKMLLIDA | 496 | Q9H422 | |
| VKTEALIRYLETMKS | 226 | Q9NUJ7 | |
| LLAKMTAKLNYAETR | 246 | Q92832 | |
| AKMYISELKNIRLRL | 1046 | Q9UPN3 | |
| VLNRMKYEITKREIL | 66 | A6NG13 | |
| RNYELMESEKTKLLI | 181 | O94905 | |
| IRVLMLLYSSEKKIF | 361 | Q86YD1 | |
| AIYNEDKLMAKALLL | 246 | A0JP26 | |
| AIYNEDKLMAKALLL | 246 | Q6S8J3 | |
| TTELIYVRKLKIMTD | 171 | Q3KR16 | |
| YVRKLKIMTDLLAAG | 176 | Q3KR16 | |
| LKYRNLKHILAMVLE | 501 | Q4G163 | |
| LAAKREMIKIDKAAY | 131 | Q8IZU1 | |
| VKMALDIEIAAYRKL | 391 | P12036 | |
| LSKSEMSLYAVLDLK | 11 | Q8N7S2 | |
| DYELARVKEILIFMI | 846 | Q9Y2I7 | |
| LRKLMELVKYMLQDT | 596 | Q9P2D7 | |
| KLIDVISMYRELLKD | 4261 | P04114 | |
| ISMYRELLKDLSKEA | 4266 | P04114 | |
| TQALAKYLKALDTRM | 271 | P07199 | |
| EIRMEFIKYLKSIIN | 156 | Q9H7X7 | |
| SLMKRLEEEIKFNLY | 261 | Q8WYA0 | |
| TRLLILADMADVYKL | 136 | P35221 | |
| LDREVVDKYSLIMKV | 311 | Q14574 | |
| LMAQDLKLKDLLKVY | 116 | Q8TD57 | |
| MVRMLDILAEYLTIK | 816 | O14647 | |
| KEEYKLSLLMAESLR | 516 | Q8IXL6 | |
| MALDVKSRAKRYEKL | 1 | P50613 | |
| MALDVEIATYRKLLE | 396 | P17661 | |
| KLLTTIKAVVMLEYV | 16 | Q13617 | |
| EVEYLLKKVLSSMSL | 141 | Q9H4E7 | |
| RKFLYELIVALLKMD | 711 | Q6ZN28 | |
| LIAEKKMQLERYRVE | 96 | Q8IY31 | |
| SLKDIKIMGYSIRTI | 481 | P22304 | |
| DLKRELSTKYLTMKI | 6086 | Q8NDH2 | |
| RKDALKAVDTVLKYM | 206 | Q6UWR7 | |
| MLKELAEILRFNYKI | 451 | Q16099 | |
| KVYLKAILRMKQLED | 121 | Q9UKT8 | |
| LQKDLRTYLASVKAM | 61 | O00499 | |
| LAIAIERYITMLKMK | 136 | P21453 | |
| TLGIMLSYIRSKKLE | 61 | A0A087WTH5 | |
| SMLEIYKEIIRDLLS | 156 | B7ZC32 | |
| LYKESLTKLMATLRN | 656 | P35580 | |
| MESKYKEILLLTSLD | 1 | W6CW81 | |
| ALGKRLKIETRYVSM | 4061 | Q8TE73 | |
| YLKDKMRKAVAEELA | 616 | Q969Z0 | |
| VLEKNKLMRYESELL | 1856 | O94851 | |
| LYHLQKSLLEMKELR | 526 | Q9UBD5 | |
| ELMDTSLDKFYRKVL | 141 | P46734 | |
| LNAMVLVATLRYKKL | 51 | P03999 | |
| MELSLNLDSKKYERI | 151 | O75818 | |
| AIYNEDKLMAKALLL | 246 | Q86YR6 | |
| IAYEERMKKLNTELR | 781 | Q8TBY8 | |
| LMSYKVLRGVLKAVT | 976 | Q8ND04 | |
| SMKAKITAYVIILAL | 331 | Q9GZS1 | |
| RIMDEKTASELKILY | 526 | Q15542 | |
| YILATLLKEDVKMLS | 551 | Q6PI48 | |
| KKDLVRRIKMLEYAL | 111 | Q13033 | |
| KDLVRRIKMLEYALK | 96 | O43815 | |
| AAEYAKLLAKRMKEA | 206 | P62753 | |
| MTKEEVTELLARYKL | 151 | P19388 | |
| KLDKDIVALMTRRAY | 251 | Q02880 | |
| MKMEFLELKYRLLSL | 501 | Q8NF91 | |
| KELRAAIDSTYRKLM | 1106 | Q8NF91 | |
| KYLQSKEDLRLMLIE | 2146 | Q8WXH0 | |
| IDAYKLLKKEMTLDL | 261 | Q5JRA6 | |
| VTEEKKLQLVRMYRT | 2131 | P58107 | |
| ERKTIKVLLEYADKM | 1231 | Q14524 | |
| YRKALDDMISTLKKI | 126 | P49368 | |
| TKLFKDDIRYLLTMD | 256 | Q9UBT2 | |
| AIYNEDKLMAKALLL | 246 | P0CG38 | |
| QRMIYATLLKRLKEE | 1236 | Q8IZU2 | |
| YALTDIPSLRKVKLM | 411 | Q7L1T6 | |
| IRMRDVVLFEKKVYL | 86 | P00747 | |
| KDLRVSDKYLLAMVI | 216 | A6NHP3 | |
| KYKNLLISDLKMERE | 331 | O94818 | |
| NLAKLLTRMYLKSEV | 326 | Q9NSD9 | |
| MRYIATITDKELLKK | 1391 | Q8IWZ3 | |
| KAELKTIAEYRAIVM | 371 | Q0VFZ6 | |
| TILRGVVLKEYLTMK | 196 | P35523 | |
| EMKTILRGVVLKEYL | 166 | P51788 | |
| FEKMYEKIDLTLLNR | 981 | Q6P2Q9 | |
| KVTAEKLMDLRNEYL | 351 | Q9UBS8 | |
| SMVRKAKYRELLLSE | 311 | P49842 | |
| LDLRQKVLYKRVMLE | 31 | A6NM28 | |
| TYDLIKDALLKANLM | 196 | P55851 | |
| EMEILKQKYRLKDLT | 1041 | O75762 | |
| TSKRKLYRDVMLENI | 26 | Q6ZN79 | |
| IKYFKVLIQEMDLRL | 2701 | Q96RL7 | |
| EAKSEYMRLLQKVLA | 96 | Q5PRF9 | |
| LEKVRMEFELTRLKY | 106 | A6NEH6 | |
| KDLRVSDKYLLAMVI | 176 | A6NNV3 | |
| KDLRVSDKYLLAMVI | 216 | P0DV79 | |
| KDLRVSDKYLLAMVI | 216 | A0A494C086 | |
| KDLRVSDKYLLAMVI | 216 | Q495Y8 | |
| KDLRVSDKYLLAMVI | 126 | A6NLX3 | |
| KDLRVSDKYLLAMVI | 216 | A6NIY4 | |
| KDLRVSDKYLLAMVI | 216 | P0CI01 | |
| MKDRLAELLDLSKQY | 1 | O75558 | |
| AFYIIMKLRSSEKVL | 726 | Q9NXL6 | |
| LDLKQKSLYREVMLE | 31 | Q96GC6 | |
| DLRVSDKYLLAMVIA | 176 | Q8NFV5 | |
| DKYIMRLQDRLLKSV | 426 | Q8IX01 | |
| MALDIEIATYRKLLE | 391 | P08670 | |
| TSKRKLYRDVMLENI | 26 | A8MWA4 | |
| KKESYSALMRELELK | 791 | Q15149 | |
| TSKRKLYRDVMLENI | 26 | A8MUZ8 | |
| RINAKETMRIAEKLY | 341 | Q13472 | |
| LFKLKERYRNVLDTM | 546 | Q9ULQ1 | |
| TSKRKLYRDVMLENI | 26 | P0CI00 | |
| TSKRKLYRDVMLENI | 26 | P0CH99 | |
| RDLEILSIMLYSSKK | 2401 | O43149 | |
| MGKAEILKYILSREI | 351 | Q8NET8 | |
| RKTIKILLEYADMIF | 961 | Q01118 | |
| ADVQIKKRLSLMYSI | 731 | Q5TAH2 | |
| KDLRVSDKYLLAMVI | 176 | A6NJR5 | |
| KTDLVRRIKMLEYAL | 111 | Q9NRL3 | |
| KLLMKEREVQSSILY | 366 | P10827 | |
| LLDMIEEKALRAKEY | 416 | Q8N3L3 | |
| KLENTMELYRLSKAL | 741 | O43314 | |
| MELYRLSKALADIVI | 746 | O43314 | |
| AMRAEEKYEISLLKK | 136 | Q2TAA8 | |
| AIYNEDKLMAKALLL | 246 | Q6S5H5 | |
| AIYNEDKLMAKALLL | 246 | A6NI47 | |
| DLTPAKLLVKIMSYR | 796 | P01266 | |
| ERDLMAKYSSLEAKL | 521 | Q9UPU7 | |
| LIAMEKRRLQKLEYE | 961 | O60293 | |
| LKLALDMEIATYRKL | 421 | Q3SY84 | |
| LKLALDMEIATYRKL | 416 | Q14CN4 | |
| LKLALDMEIATYRKL | 431 | Q7RTS7 | |
| KMALDIEIAAYRKLL | 391 | P07197 |